<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">13758</article-id><article-id pub-id-type="doi">10.7554/eLife.13758</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>The Apelin receptor enhances Nodal/TGFβ signaling to ensure proper cardiac development</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-48038"><name><surname>Deshwar</surname><given-names>Ashish R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="data-ro1"/></contrib><contrib contrib-type="author" id="author-28587"><name><surname>Chng</surname><given-names>Serene C</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10931"><name><surname>Ho</surname><given-names>Lena</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-28355"><name><surname>Reversade</surname><given-names>Bruno</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4070-7997</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-42563"><name><surname>Scott</surname><given-names>Ian C</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6665-1410</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="data-ro1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Program in Developmental and Stem Cell Biology</institution>, <institution>The Hospital for Sick Children</institution>, <addr-line><named-content content-type="city">Toronto</named-content></addr-line>, <country>Canada</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Department of Molecular Genetics</institution>, <institution>University of Toronto</institution>, <addr-line><named-content content-type="city">Toronto</named-content></addr-line>, <country>Canada</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Institute of Medical Biology</institution>, <institution>A*STAR</institution>, <addr-line><named-content content-type="city">Singapore</named-content></addr-line>, <country>Singapore</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Institute of Molecular and Cellular Biology</institution>, <institution>A*STAR</institution>, <addr-line><named-content content-type="city">Singapore</named-content></addr-line>, <country>Singapore</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">Department of Paediatrics, School of Medicine</institution>, <institution>National University of Singapore</institution>, <country>Singapore</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">Heart and Stroke/Richard Lewar Centre of Excellence in Cardiovascular Research</institution>, <institution>University of Toronto</institution>, <addr-line><named-content content-type="city">Toronto</named-content></addr-line>, <country>Canada</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Robertson</surname><given-names>Elizabeth</given-names></name><role>Reviewing editor</role><aff id="aff7"><institution>University of Oxford</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><email>bruno@reversade.com</email> (BR);</corresp><corresp id="cor2"><email>ian.scott@sickkids.ca</email> (ICS)</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>14</day><month>04</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>5</volume><elocation-id>e13758</elocation-id><history><date date-type="received"><day>13</day><month>12</month><year>2015</year></date><date date-type="accepted"><day>11</day><month>04</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Deshwar et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Deshwar et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-13758-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.13758.001</object-id><p>The Apelin receptor (Aplnr) is essential for heart development, controlling the early migration of cardiac progenitors. Here we demonstrate that in zebrafish Aplnr modulates Nodal/TGFβ signaling, a key pathway essential for mesendoderm induction and migration. Loss of Aplnr function leads to a reduction in Nodal target gene expression whereas activation of Aplnr by a non-peptide agonist increases the expression of these same targets. Furthermore, loss of Aplnr results in a delay in the expression of the cardiogenic transcription factors <italic>mespaa/ab</italic>. Elevating Nodal levels in <italic>aplnra/b</italic> morphant and double mutant embryos is sufficient to rescue cardiac differentiation defects. We demonstrate that loss of Aplnr attenuates the activity of a point source of Nodal ligands Squint and Cyclops in a non-cell autonomous manner. Our results favour a model in which Aplnr is required to fine-tune Nodal output, acting as a specific rheostat for the Nodal/TGFβ pathway during the earliest stages of cardiogenesis.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13758.001">http://dx.doi.org/10.7554/eLife.13758.001</ext-link></p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.13758.002</object-id><title>eLife digest</title><p>In one of the first events that happens as an embryo develops, cells become the different stem cell populations that form the body’s organs. So what makes a cell become one stem cell type rather than another? In the case of the heart, the first important event is the activity of a signaling pathway called the Nodal/TGFβ pathway. Nodal signaling can drive cells to become many different stem cell types depending on its level of activity. Many different levels of regulation fine-tune Nodal signaling to produce these activity thresholds.</p><p>Zebrafish that have a mutation in the gene that encodes a protein called the Apelin receptor have no heart. The loss of this receptor interferes with how heart stem cells (called cardiac progenitors) are made and how they move to where heart development occurs.</p><p>Deshwar et al. have now studied mutant zebrafish in order to investigate how the Apelin receptor influences early heart development. This revealed that Nodal signaling levels are slightly lower in the mutant zebrafish embryos than in normal fish at the time when Nodal activity induces cardiac progenitors to form. When Nodal activity is experimentally boosted in zebrafish that lack the Apelin receptor, they become able to develop hearts.</p><p>Deshwar et al. also found that the Apelin receptor does not work in cells that produce or receive Nodal signals. This suggests that the Apelin receptor modulates Nodal signaling levels by acting in cells that lie between the cells that release Nodal signals and the cardiac progenitors. An important question for future work to address is how this modulation works. As Nodal is a key determinant of many cell types in developing embryos, learning how Apelin receptors regulate its activity could help researchers to derive specific cell types from cultured stem cells for use in regenerative medicine.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13758.002">http://dx.doi.org/10.7554/eLife.13758.002</ext-link></p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author Keywords</title><kwd>Aplnr</kwd><kwd>Nodal</kwd><kwd>cardiac progenitors</kwd><kwd>heart development</kwd><kwd>mesendoderm</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research Organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>Operating Grant 86663</award-id><principal-award-recipient><name><surname>Deshwar</surname><given-names>Ashish R</given-names></name><name><surname>Scott</surname><given-names>Ian C</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001348</institution-id><institution>Agency for Science, Technology and Research</institution></institution-wrap></funding-source><award-id>Strategic Positioning Fund on Genetic Orphan Diseases</award-id><principal-award-recipient><name><surname>Reversade</surname><given-names>Bruno</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>elife-xml-version</meta-name><meta-value>2.5</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The Apelin receptor acts as a rheostat to ensure that the proper levels of Nodal signaling are achieved for proper cell fate specification at the onset of gastrulation, in particular for cardiac progenitor development.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>During gastrulation, complex cell movements occur which result in the localization of progenitor populations to discrete embryonic regions for subsequent organogenesis. Loss of Apelin receptor (Aplnr) function in zebrafish, as manifested in the recessive <italic>grinch</italic> mutant, results in a decrease or absence of cardiogenesis, and affects expression of the earliest known cardiac mesoderm markers (<xref ref-type="bibr" rid="bib48">Scott et al., 2007</xref>; <xref ref-type="bibr" rid="bib57">Zeng et al., 2007</xref>). The role of Aplnr in the proper formation of the heart appears to be conserved in vertebrates. In mice, <italic>Aplnr</italic> (also known as <italic>Apj</italic> and <italic>Agtrl1</italic>) is expressed in the gastrulating mesoderm, with <italic>Aplnr</italic> mutant mice exhibiting incompletely penetrant cardiovascular malformations including thinning of the myocardium, ventricular septation defects, an enlarged right ventricle and improper heart looping (<xref ref-type="bibr" rid="bib27">Kang et al., 2013</xref>). In vitro, overexpression of <italic>Aplnr</italic> in mouse embryonic stem cells results in enhanced cardiac differentiation of embryoid bodies, while <italic>Aplnr</italic> inhibition leads to impaired cardiac differentiation (<xref ref-type="bibr" rid="bib15">D'Aniello et al., 2013</xref>; <xref ref-type="bibr" rid="bib14">D'Aniello et al., 2009</xref>).</p><p>While a role for Aplnr signaling in the earliest events of cardiac development is evident, how Aplnr functions in this context remains unclear. In zebrafish, Aplnr has been implicated in the movement of cardiac progenitors during gastrulation to the anterior lateral plate mesoderm (ALPM), the site of heart development, with a delay in anterior migration of presumed cardiac progenitors during gastrulation (<xref ref-type="bibr" rid="bib40">Paskaradevan and Scott, 2012</xref>). These early effects on gastrulation movements suggest an early function for Aplnr in cardiac development, well before expression of cardiac mesoderm genes, such as <italic>Nkx2.5</italic>, is initiated (<xref ref-type="bibr" rid="bib48">Scott et al., 2007</xref>; <xref ref-type="bibr" rid="bib57">Zeng et al., 2007</xref>; <xref ref-type="bibr" rid="bib40">Paskaradevan and Scott, 2012</xref>; <xref ref-type="bibr" rid="bib41">Pauli et al., 2014</xref>; <xref ref-type="bibr" rid="bib12">Chng et al., 2013</xref>). Interestingly, the requirement for Aplnr in cardiac development appears to be primarily non-cell autonomous, which is to say that Aplnr is not required in the cells that will form the heart per se but rather in surrounding cells (<xref ref-type="bibr" rid="bib40">Paskaradevan and Scott, 2012</xref>). The genetic deletion of <italic>aplnrb</italic> or its endogenous early ligand <italic>elabela</italic> (also known as <italic>apela or toddler</italic>) causes gastrulation movement defects with aberrant cardiac and endoderm development in zebrafish (<xref ref-type="bibr" rid="bib40">Paskaradevan and Scott, 2012</xref>; <xref ref-type="bibr" rid="bib41">Pauli et al., 2014</xref>; <xref ref-type="bibr" rid="bib12">Chng et al., 2013</xref>). This, together with the ability of overexpressed Aplnr to rescue cardiac differentiation in <italic>Cripto</italic>-null mouse embryonic stem cells (<xref ref-type="bibr" rid="bib14">D'Aniello et al., 2009</xref>), indicate a strong functional link between Aplnr and Nodal signaling for proper cardiac specification and differentiation.</p><p>In this study we report that Aplnr directly modulates Nodal/TGFβ signaling during gastrulation, a key pathway essential for mesendoderm induction and migration (<xref ref-type="bibr" rid="bib8">Carmany-Rampey and Schier, 2001</xref>; <xref ref-type="bibr" rid="bib16">Dougan et al., 2003</xref>). Several lines of evidence show that levels of Nodal activity are attenuated in <italic>aplnr</italic> mutants. Loss-of-function of Aplnr leads to a reduction in Nodal target gene expression, whereas activation of Aplnr signaling increases the expression of these same targets. By elevating Nodal levels in <italic>aplnr</italic> mutant/morphant embryos, we are able to restore cardiac differentiation. We find that loss of Aplnr attenuates the activity of a point source of the Nodal ligands Squint (Sqt, Ndr1) and Cyclops (Cyc, Ndr2) and that the Aplnr regulates Nodal signaling in a cell non-autonomous fashion. We propose a model in which the Aplnr fine-tunes Nodal activity during the onset of gastrulation to initiate the migration of lateral margin cells and proper heart formation. Aplnr may therefore act as a rheostat for the Nodal/TGFβ pathway.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Aplnra and aplnrb function redundantly in cardiac and endoderm development</title><p>The zebrafish genome harbours two paralogues (<italic>aplnra</italic> and <italic>aplnrb</italic>) of the human <italic>APLNR</italic> gene. Only <italic>aplnrb</italic>, for which the first mutant was aptly named <italic>grinch (aplnrb<sup>s608</sup>,</italic> p.Trp90Leu), is known to be involved in early cardiogenesis (<xref ref-type="bibr" rid="bib48">Scott et al., 2007</xref>; <xref ref-type="bibr" rid="bib57">Zeng et al., 2007</xref>). In order to assess the contribution of <italic>aplnra</italic> to the process of gastrulation and heart development, we knocked it out using custom TALEN pairs targeted to its unique exon on chromosome 8 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). The resulting null allele, which we named <italic>max</italic> (the compliant dog companion of the Grinch), encodes a truncated 17-amino acid protein resulting from an early frameshift. The <italic>aplnra<sup>max</sup></italic> allele (p.Thr16TrpfsX2) deletes 95% of Aplnra including its seven transmembrane domains (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Present at sub-Mendelian ratios, approximately 15% of mutant larvae from heterozygous <italic>aplnra<sup>max</sup></italic> intercrosses showed pericardial edema (<xref ref-type="fig" rid="fig1">Figure 1B–C</xref>). As with <italic>aplnrb</italic> mutants (<xref ref-type="bibr" rid="bib48">Scott et al., 2007</xref>; <xref ref-type="bibr" rid="bib41">Pauli et al., 2014</xref>; <xref ref-type="bibr" rid="bib12">Chng et al., 2013</xref>), <italic>sox17</italic>-positive endodermal progenitors at 8 hr post-fertilization (hpf) and <italic>myl7</italic>-positive cardiomyocytes at 1 day post-fertilization (dpf) were significantly reduced in numbers and intensity in a<italic>plnra<sup>max</sup></italic> fish (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–D</xref>). Note that in this current study a novel <italic>aplnrb<sup>hu4145</sup></italic> (p.W54X) allele is being used. An independent allele, <italic>aplnra<sup>ins</sup></italic>, resulting from a viral insertion was obtained from Znomics (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Homozygous <italic>aplnra<sup>ins</sup></italic> embryos recapitulated the phenotype of <italic>aplnra<sup>max</sup></italic> and <italic>aplnrb<sup>hu4145</sup></italic> with similar pericardial edema (<xref ref-type="fig" rid="fig1">Figure 1D</xref>), reduced <italic>nkx2.5</italic>-positive cardiac mesoderm at the 15-somite stage (<xref ref-type="fig" rid="fig1">Figure 1F–H</xref>) and reduced <italic>myl7</italic>-positive cells at 2 dpf (<xref ref-type="fig" rid="fig1">Figure 1J–K</xref>). The number and spread of <italic>sox17</italic>-positive cells was significantly reduced in homozygous <italic>aplnra<sup>ins</sup></italic> when compared to wildtype (WT) and was not significantly different from <italic>aplnrb<sup>hu4145</sup></italic> single mutants (<xref ref-type="fig" rid="fig1">Figure 1M–O</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E–F</xref>). These <italic>aplnra</italic> mutant phenotypes suggest redundant functions for <italic>aplnra</italic> and <italic>aplnrb</italic>.<fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.13758.003</object-id><label>Figure 1.</label><caption><title><italic>aplnra</italic> mutant embryos display defects in endoderm and heart formation.</title><p>(<bold>A</bold>) Schematic detailing the <italic>aplnra<sup>max</sup></italic> and <italic>aplnra<sup>ins</sup></italic> alleles. TM indicates the transmembrane domain. (<bold>B–E</bold>) Gross morphology of <italic>aplnra<sup>max</sup>,aplnra<sup>ins</sup></italic> and <italic>aplnra<sup>ins</sup>; aplnrb<sup>hu4145</sup></italic> mutant embryos compared to WT (wild type) at 48 hpf (hours post-fertilization). (<bold>F–I</bold>) <italic>nkx2.5</italic> expression at the 15 somite stage in WT, <italic>aplnrb<sup>hu4145</sup>, aplnra<sup>ins</sup></italic>, and <italic>aplnra<sup>ins</sup>; aplnrb<sup>hu4145</sup></italic> mutant embryos. Dorsal view with anterior to the top. (<bold>J–L</bold>) In situ hybridization showing expression of <italic>myl7</italic> at 48 hpf in <italic>aplnra<sup>ins</sup></italic> and <italic>aplnra<sup>ins</sup></italic>; <italic>aplnrb<sup>hu4145</sup></italic> embryos compared to WT when viewed from the anterior. (<bold>M–P</bold>) Comparison of <italic>sox17</italic> expression at 8 hpf between WT, <italic>aplnra<sup>ins</sup></italic>, <italic>aplnrb<sup>hu4145</sup> </italic>and <italic>aplnra<sup>ins</sup></italic>; <italic>aplnrb<sup>hu4145</sup></italic> mutant embryos. Dorsal views are shown with a lateral view in inset panels.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13758.003">http://dx.doi.org/10.7554/eLife.13758.003</ext-link></p></caption><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-13758-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.13758.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title><italic>aplnra</italic> and <italic>aplnra; aplnrb</italic> double mutant characterization.</title><p>(<bold>A–D</bold>) Wholemount RNA in situ hybridization (WISH) showing expression of <italic>sox17</italic> at 8 hpf and <italic>myl7</italic> at 24 hpf in <italic>aplnra<sup>max</sup></italic> embryos compared to WT. (<bold>E–F</bold>) Quantification of the number and spread of <italic>sox17</italic>-positive cells in WT, <italic>aplnra<sup>ins</sup>, aplnrb<sup>hu4145</sup> </italic>and <italic>aplnra<sup>ins</sup>; aplnrb<sup>hu4145</sup></italic> embryos at 8 hpf. Data are represented as means ± SEM. *p&lt;0.05, **p&lt;0.01, n.s. = not significant unpaired two-tailed t-test.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13758.004">http://dx.doi.org/10.7554/eLife.13758.004</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-13758-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.13758.005</object-id><label>Figure 1—figure supplement 2.</label><caption><title><italic>aplnra; aplnrb</italic> double mutants display defects in endodermal organ development.</title><p>(<bold>A–I</bold>) WISH showing expression of <italic>foxa1</italic> (<bold>A–C</bold>), <italic>foxa2</italic> (<bold>D–F</bold>) and <italic>foxa3</italic> (<bold>G–I</bold>) at 48 hpf in WT and <italic>aplnra<sup>ins</sup>; aplnrb<sup>hu4145</sup></italic> homozygous mutant embryos. P indicates the pancreatic bud, L indicates the liver bud and the arrow indicates the most anterior pharyngeal endoderm. For double mutants, two representative images are shown for each probe (n=7 for each marker). Embryos are visualized ventrally.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13758.005">http://dx.doi.org/10.7554/eLife.13758.005</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-13758-fig1-figsupp2-v2.tif"/></fig></fig-group></p><p>Double <italic>aplnrb<sup>hu4145</sup>; aplnra<sup>ins</sup></italic> mutants were generated to evaluate functional redundancy for these two paralogues in early development. Double mutant embryos exhibited normal morphology at 2 dpf with pericardial edema (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). In contrast to <italic>aplnra</italic> or <italic>aplnrb</italic> single mutants, which usually possess significant cardiac tissue at 2 dpf, double mutant embryos exhibited either complete absence of or an extremely small heart (<xref ref-type="fig" rid="fig1">Figure 1L</xref>). In addition, double <italic>aplnra; aplnrb</italic> mutant embryos exhibited a further reduction in both the spread and number of <italic>sox17</italic> expressing cells when compared to the <italic>aplnra<sup>ins</sup></italic> or <italic>aplnrb<sup>hu4145</sup></italic> single mutants (<xref ref-type="fig" rid="fig1">Figure 1M–P</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E–F</xref>). <italic>nkx2.5</italic> expression was negligible in double mutants suggesting a near-complete absence of early cardiac progenitors (<xref ref-type="fig" rid="fig1">Figure 1I</xref>). It should be noted that the double mutant phenotype faithfully phenocopies that seen with the injection of <italic>aplnra/b</italic> morpholinos (MOs) both at the morphological and molecular levels as seen by the expression of these three diagnostic markers <italic>sox17, nkx2.5</italic> and <italic>myl7</italic> (<xref ref-type="bibr" rid="bib40">Paskaradevan and Scott, 2012</xref>; <xref ref-type="bibr" rid="bib12">Chng et al., 2013</xref>).</p><p>Given the substantial reduction in the number of endodermal progenitors during gastrulation in <italic>aplnra; aplnrb</italic> double mutants, we investigated the subsequent effects on development of the endodermal-derived organs. The morphology of the gut tube was examined by performing wholemount RNA in situ hybridization (WISH) for <italic>foxa1, foxa2</italic> and <italic>foxa3</italic> at 48 hpf. While the pharyngeal endoderm appeared to be primarily intact, the most anterior population of these cells appeared to be either dramatically reduced or absent in double mutants (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A–I</xref>). Furthermore, the liver and pancreatic buds were consistently found to be smaller or absent, with misorientation of the pancreatic bud evident in some embryos. Taken together, this data suggests that Aplnra is required for both proper endoderm differentiation and cardiac development and that Aplnra and Aplnrb have redundant roles in these early processes.</p></sec><sec id="s2-2"><title>Aplnr activation enhances Nodal signaling during gastrulation</title><p>To gain insight into how Aplnr signaling regulates early cardiac development, we pursued a gene expression profiling approach. Comparative microarray analysis at 50% epiboly (5 hpf) of cDNA from WT and double <italic>aplnra/b</italic> morphants (injected with MOs) embryos revealed a reduction in a set of genes known to be downstream of the Nodal signaling pathway. Previous work has identified 72 Nodal-regulated genes in zebrafish at 6 hpf (<xref ref-type="bibr" rid="bib6">Bennett et al., 2007</xref>). Remarkably nearly one-third (23 out of 72) of these genes were down-regulated in <italic>aplnra/b</italic> morphants (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The estimated probability of observing such a large overlap by chance is very small (8.6 × 10<sup>-17</sup> by hypergeometric distribution), suggesting that this overlap might be biologically significant, <italic>i.e.</italic> that Nodal signaling is decreased in the absence of Aplnr function. Conversely, using Gene Set Enrichment Analysis (GSEA) (<xref ref-type="bibr" rid="bib49">Subramanian et al., 2005</xref>), we found that the genes downregulated in <italic>aplnra/b</italic> morphants were significantly enriched for genes upregulated in zebrafish sphere stage embryos injected with <italic>sqt</italic> mRNA, which encodes for one of the activating Nodal ligands Squint (<xref ref-type="bibr" rid="bib36">Nelson et al., 2014</xref>), further substantiating our hypothesis that Aplnra/b promotes Nodal signaling (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Given the known role of Nodal signaling in induction and migration of the mesendoderm (<xref ref-type="bibr" rid="bib8">Carmany-Rampey and Schier, 2001</xref>; <xref ref-type="bibr" rid="bib18">Feldman et al., 2000</xref>; <xref ref-type="bibr" rid="bib21">Gritsman et al., 1999</xref>), we surmised that Aplnr might work upstream, or in parallel, to the Nodal pathway. To more directly assess Nodal signaling levels in the embryo, we injected a Nodal/TGFβ luciferase reporter construct into WT, <italic>aplnra/b</italic> MOs, <italic>oep</italic> MO and <italic>lefty1/2</italic> MOs injected embryos. At 30% epiboly (4.7 hpf), embryos injected with MOs against the Nodal pathway antagonist <italic>lefty1/2</italic> had higher levels of Nodal/TGFβ luciferase reporter activity, while those injected with a MO against the essential Nodal co-receptor <italic>oep</italic> (also known as <italic>cripto</italic> or <italic>tdgf1</italic>) had lower levels (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Consistently, <italic>aplnra/b</italic> morphant embryos exhibited significantly lower levels of Nodal/TGFβ reporter activity compared to WT, indicating a reduction in Nodal signaling in these embryos, in agreement with our microarray results. We next sought to confirm attenuated Nodal signaling following <italic>aplnra/b</italic> knockdown by means of chemical inhibition. Embryos were incubated from the sphere stage (4hpf) onwards with increasing concentrations of SB431542, which acts as a dedicated Alk4/5/7 antagonist. Phenotypes were scored according to the severity of cyclopia, a hallmark feature of Nodal impairment in zebrafish (<xref ref-type="bibr" rid="bib21">Gritsman et al., 1999</xref>; <xref ref-type="bibr" rid="bib42">Rebagliati et al., 1998</xref>), at 2 dpf (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Following multiple independent tests (N=4) <italic>aplnra/b</italic> morphants were found to be significantly more sensitive to SB431542 treatment than were WT embryos (<xref ref-type="fig" rid="fig2">Figure 2D–E</xref>), suggesting reduced (but not absent) Nodal signaling levels when Aplnr is lost.<fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.13758.006</object-id><label>Figure 2.</label><caption><title>Aplnr deficient embryos exhibit a reduction in Nodal signaling.</title><p>(<bold>A</bold>) List and Venn diagram of 23 Nodal target genes found to be down-regulated in a microarray of <italic>aplnra/b</italic> morphant embryos compared to WT at 50% epiboly (5.25 hpf). (<bold>B</bold>) Relative luciferase activity regulated by the Activin response element (ARE) in WT, <italic>aplnra/b</italic> morpholino (MO), <italic>oep</italic> MO and <italic>lefty1/2</italic> MO injected embryos at 30% epiboly (4.7 hpf). Data are represented as means ± SEM. *p&lt;0.05 unpaired two-tailed t-test. (<bold>C–E</bold>) Phenotypic characterization of WT (<bold>D</bold>) and <italic>aplnra/b</italic> morphant embryos (<bold>E</bold>) when treated with the indicated concentration of the Alk4/5/7 inhibitor SB431542 from the sphere stage (4 hpf) onwards. (<bold>F–S</bold>) Visualization of the expression of the canonical nodal target genes <italic>gsc, flh</italic> and <italic>sox3</italic>2 in WT (<bold>F</bold>,<bold>J</bold>,<bold>N</bold>), <italic>aplnra/b</italic> MOs injected (<bold>G</bold>,<bold>K</bold>,<bold>O</bold>), <italic>aplnra<sup>ins</sup>; aplnrb<sup>hu4145</sup></italic> double mutant (<bold>H</bold>,<bold>L</bold>,<bold>P</bold>) and <italic>aplnrb</italic> RNA injected treated with the Aplnr agonist ML233 (<bold>I</bold>,<bold>M</bold>,<bold>Q</bold>) embryos at 8 hpf. Embryos are viewed from the dorsal side. Quantification of the number and spread of <italic>sox32</italic> expressing cells (R,S). Data are represented as means ± SEM. *p&lt;0.05, **p&lt;0.01 unpaired two-tailed t-test.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13758.006">http://dx.doi.org/10.7554/eLife.13758.006</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-13758-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.13758.007</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Loss of aplnr affects Nodal target gene expression.</title><p>(<bold>A</bold>) Gene set enrichment analysis (GSEA) of genes downregulated in <italic>aplnra/b</italic> morphants when compared against genes upregulated in zebrafish sphere stage (4 hpf) embryos injected with <italic>sqt</italic> mRNA. (<bold>B–G</bold>) WISH showing expression of <italic>lefty1</italic> at 4 hpf (<bold>B</bold>, <bold>E</bold>) and 5.5 hpf (<bold>C</bold>, <bold>F</bold>) and <italic>lefty2</italic> at 5.5 hpf (<bold>D</bold>, <bold>G</bold>) in <italic>aplnra/b</italic> morphant embryos when compared to WT from an animal pole (top of embryo) view.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13758.007">http://dx.doi.org/10.7554/eLife.13758.007</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-13758-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.13758.008</object-id><label>Figure 2—figure supplement 2.</label><caption><title>Aplnr activation enhances Nodal target gene expression.</title><p>(<bold>A–I</bold>) Expression of the canonical Nodal target genes <italic>gsc, flh</italic> and <italic>sox3</italic>2 in WT (<bold>A–C</bold>), <italic>aplnrb</italic> RNA injected embryos (<bold>D–F</bold>) and embryos treated with the Aplnr agonist ML233 (<bold>G–I</bold>) at 8 hpf. Embryos are viewed from the dorsal side with anterior to the top. (<bold>J–O</bold>) Expression of the canonical Nodal target genes <italic>gsc, flh</italic> and <italic>sox3</italic>2 in <italic>aplnra/b</italic> morphant embryos with or without ML233 at 8 hpf. Embryos are viewed from the dorsal side with anterior to the top. (<bold>P–U</bold>) Expression of the canonical Nodal target genes <italic>gsc, flh</italic> and <italic>sox3</italic>2 in <italic>oep</italic> morphant embryos with or without the injection of <italic>aplnrb</italic> RNA and addition of ML233 at 8 hpf. Embryos are viewed from the dorsal side with anterior to the top.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13758.008">http://dx.doi.org/10.7554/eLife.13758.008</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-13758-fig2-figsupp2-v2.tif"/></fig></fig-group></p><p>We next used WISH to assess the expression of direct downstream targets of Nodal in double <italic>aplnra/b</italic> morphant embryos. The canonical Nodal target genes <italic>floating head (flh), goosecoid (gsc</italic>) and <italic>sox32</italic> (<xref ref-type="bibr" rid="bib21">Gritsman et al., 1999</xref>; <xref ref-type="bibr" rid="bib11">Chen and Schier, 2001</xref>) all showed reduced expression in <italic>aplnra/b</italic> morphant embryos at 8 hpf relative to WT embryos (<xref ref-type="fig" rid="fig2">Figure 2F–G, J–K, N–O</xref>). Analysis of <italic>sox32</italic> expression, which marks endodermal precursors, revealed both a reduced number of endoderm cells and a decreased extent of endodermal migration (quantified in <xref ref-type="fig" rid="fig2">Figure 2R–S</xref>), consistent with previous analysis of <italic>aplnrb</italic> mutants (<xref ref-type="bibr" rid="bib41">Pauli et al., 2014</xref>; <xref ref-type="bibr" rid="bib12">Chng et al., 2013</xref>). Down-regulation of all three genes was also documented in <italic>aplnra; aplnrb</italic> double mutant embryos (<xref ref-type="fig" rid="fig2">Figure 2H,L,P</xref>). Further analysis of additional Nodal target genes <italic>lefty1</italic> and <italic>lefty2</italic> also revealed a decrease in expression before and at the beginning of gastrulation (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B–G</xref>).</p><p>We next examined if the ectopic activation of Aplnr could be sufficient to increase the expression of Nodal target genes. Overexpression of the ligands of Aplnr, Elabela and Apelin, each result in phenotypes similar to Aplnr loss-of-function, possibly as a consequence of ligand-mediated receptor internalization and signal desensitisation (<xref ref-type="bibr" rid="bib48">Scott et al., 2007</xref>; <xref ref-type="bibr" rid="bib57">Zeng et al., 2007</xref>; <xref ref-type="bibr" rid="bib40">Paskaradevan and Scott, 2012</xref>; <xref ref-type="bibr" rid="bib41">Pauli et al., 2014</xref>; <xref ref-type="bibr" rid="bib12">Chng et al., 2013</xref>). To bypass this limitation, we instead used ML233, a non-peptide small molecule agonist of Aplnr signaling (<xref ref-type="bibr" rid="bib29">Khan et al., 2011</xref>). Treating embryos injected with 150 pg of <italic>aplnrb</italic> RNA with 2.5 μM of ML233 resulted in a significant increase in the expression of the three Nodal targets <italic>gsc, flh</italic> and <italic>sox32</italic> relative to WT (<xref ref-type="fig" rid="fig2">Figure 2I,M,Q</xref>) and increased both the number of endoderm cells and the extent of migration to a more anterior position (<xref ref-type="fig" rid="fig2">Figure 2R–S</xref>). Overexpression of <italic>aplnrb,</italic> or ML233 treatment alone, resulted in increased <italic>flh</italic> and <italic>gsc</italic> expression, whereas <italic>sox32</italic> expression and endoderm migration was largely unaffected (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A–I</xref>). ML233 had no effect on <italic>gsc, flh</italic> or <italic>sox32</italic> expression in <italic>aplnra/b</italic> morphants, indicating that the action of ML233 is Aplnr-dependent (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2J–O</xref>). Moreover, overexpression of <italic>aplnrb</italic> in <italic>oep</italic>-depleted embryos was not sufficient to induce expression of <italic>gsc, flh</italic> or <italic>sox32</italic>, even in the presence of ML233 (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2P–U</xref>). This argues against a scenario where Aplnr signaling is acting in parallel to Nodal signaling. Taken all together, these data suggest that Aplnr signaling is sufficient to boost endogenous levels of Nodal signaling at gastrulation stages.</p></sec><sec id="s2-3"><title>Elevated Nodal levels rescue the aplnr loss-of-function heart phenotype</title><p>As Nodal signaling is reduced in <italic>aplnr</italic> mutant embryos, we reasoned that increasing Nodal may ameliorate or rescue cardiogenesis in the absence of Aplnr function. To test this hypothesis, we took two complementary approaches. We first elevated the levels of endogenous Nodal signaling by injecting a MO against <italic>lefty1</italic>, a direct negative feedback Nodal antagonist (<xref ref-type="bibr" rid="bib20">Feldman et al., 2002</xref>). <italic>lefty1</italic> MO was injected into embryos bearing two different <italic>aplnrb</italic> mutant alleles, <italic>s608/grinch</italic> (p.W90L) and <italic>hu4145</italic> (p.W54X), which exhibit a small heart (<xref ref-type="fig" rid="fig3">Figure 3A–C</xref>). While the penetrance of the heart phenotype varied within each clutch, <italic>lefty1</italic> MO treatment was capable of rescuing cardiogenesis in both mutants, with nearly all embryos showing rescue of the small heart phenotype (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, note that 25% of embryos in a given cross would be homozygous null mutants, data for 2 independent clutches per mutant is shown). One caveat of this approach is that <italic>aplnra/b</italic> gene expression is regulated by Nodal signaling (<xref ref-type="bibr" rid="bib14">D'Aniello et al., 2009</xref>; <xref ref-type="bibr" rid="bib41">Pauli et al., 2014</xref>). It is therefore conceivable that elevating Nodal levels in <italic>aplnrb</italic> single mutants provides rescue simply by elevating <italic>aplnra</italic> gene expression. To address this issue, <italic>lefty1</italic> MO was injected into embryos generated from an in-cross of <italic>aplnra; aplnrb</italic> heterozygous parents. Embryos were evaluated for heart formation by WISH for <italic>myl7</italic> gene expression and subsequently genotyped. Strikingly, over 60% of <italic>aplnra/b</italic> double mutants exhibited proper cardiac formation when injected with <italic>lefty1</italic> MOs, which was not observed in un-injected mutant siblings (<xref ref-type="fig" rid="fig3">Figure 3E–H</xref>). This suggests that elevated Nodal signaling is capable of rescuing the Aplnr cardiac phenotype, even in the complete absence of Aplnr function.<fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.13758.009</object-id><label>Figure 3.</label><caption><title>Elevation of Nodal signaling in <italic>aplnr</italic> mutant/morphant embryos rescues cardiogenesis.</title><p>(<bold>AC</bold>) <italic>myl7</italic> WISH showing a representative heart phenotype at 48 hpf in a WT embryo (<bold>A</bold>) and two different <italic>aplnrb</italic> mutant alleles; <italic>hu4145</italic> (<bold>B</bold>) and <italic>s608/grinch</italic> (<bold>C</bold>). Anterior is oriented towards the left. (<bold>D</bold>) Quantification of the number of embryos with a small heart at 48 hpf from individual clutches of embryos in which half were injected with <italic>lefty1</italic> MO. Clutches were obtained from crosses of two different <italic>aplnrb</italic> heterozygous mutants (<italic>hu4145</italic> and <italic>s608/grinch</italic> as indicated). (<bold>E–H</bold>) Classification of heart phenotype in <italic>aplnra<sup>ins</sup>; aplnrb<sup>hu4145</sup></italic> double mutant embryos at 48 hpf when injected with <italic>lefty1</italic> MO as compared to un-injected embryos. Severity of cardiac phenotypes was scored based on <italic>myl7</italic> WISH (<bold>H</bold>). (<bold>I</bold>) Schematic displaying the transplantation of injected donor cells into the margin of host embryos. Contribution of transplanted cells to the heart is scored based on expression of the <italic>myl7:EGFP</italic> transgene in donor cells. (<bold>J–N”</bold>) Margin transplants of WT or <italic>tar*</italic> (activated Nodal receptor) overexpressing <italic>myl7:EGFP</italic> cells into WT or <italic>aplnra/b</italic> morphant embryos at 48 hpf. Arrow indicates the heart. Embryos are displayed from a lateral view with the anterior of the embryo towards the right. Data are represented as means ± SEM. *p&lt;0.05, n.s. = not significant, Tukey’s Multiple Comparison test following significant (p&lt;0.05) one way ANOVA. (<bold>O–-R</bold>) Gross morphology and <italic>myl7</italic> expression at 24 hpf in WT (<bold>O</bold>), embryos injected with a sub-optimal dose of <italic>oep</italic> MOs (<bold>P</bold>), <italic>aplnra/b</italic> morphant embryos (<bold>Q</bold>) and <italic>aplnra/b/oep</italic> morphant embryos (<bold>R</bold>).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13758.009">http://dx.doi.org/10.7554/eLife.13758.009</ext-link></p></caption><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-13758-fig3-v2.tif"/></fig></p><p>As a complementary approach, we attempted to specifically elevate the levels of Nodal signaling within lateral margin cells and see if this rescued cardiac contribution. To perform this experiment, donor cells from <italic>myl7:EGFP</italic> transgenic embryos either injected or uninjected with <italic>taram-a* (tar*)</italic> RNA encoding a hyper-activated Nodal receptor (<xref ref-type="bibr" rid="bib43">Renucci et al., 1996</xref>) were transplanted to the margin of <italic>aplnra/b</italic> morphant hosts (<xref ref-type="fig" rid="fig3">Figure 3I</xref>). As we have previously shown (<xref ref-type="bibr" rid="bib48">Scott et al., 2007</xref>; <xref ref-type="bibr" rid="bib40">Paskaradevan and Scott, 2012</xref>), WT cells placed at the margin of <italic>aplnra/b</italic> morphant hosts contributed to the myocardium at an appreciably reduced frequency (7.8%, N=3, n=157) as compared to when WT hosts were used (<xref ref-type="fig" rid="fig3">Figure 3J</xref>). In contrast, <italic>tar*</italic> overexpressing cells, when transplanted to the margin of <italic>aplnra/b</italic> morphant embryos, contributed to the myocardium at a much higher frequency (20.7%, N=3, n=164) with no significant difference when compared to transplantation of WT cells into WT hosts (22.5%, N=4, n=234), suggesting a near complete rescue (<xref ref-type="fig" rid="fig3">Figure 3J–N”</xref>). It should be noted that transplantation of WT <italic>tar*</italic> expressing cells into the margin of WT embryos did not increase the contribution of donor cells to the heart (22%, N=4, n=213). These experiments further argue that the heart defects observed in <italic>aplnr</italic> deficient embryos are suppressed if Nodal signaling is increased. To confirm that the absence of Aplnr results in lower Nodal activity, which consequently reduces/eliminates cardiogenesis, we further compromised Nodal signaling by partially depleting the embryo of Oep, the obligate Nodal co-receptor (<xref ref-type="bibr" rid="bib21">Gritsman et al., 1999</xref>). In conditions where <italic>oep</italic> MO injections induced cardia bifida (<xref ref-type="fig" rid="fig3">Figure 3O–P</xref>), we observed that triple <italic>aplnra/aplnrb/oep</italic>-depleted embryos displayed more severe defects, including cyclopia, and were completely devoid of <italic>myl7</italic> expression at 1 dpf (<xref ref-type="fig" rid="fig3">Figure 3Q–R</xref>). Collectively these results argue that Aplnra/b directly promotes Nodal signaling to ensure proper heart formation, with lower levels of Nodal signal being received by presumptive cardiac progenitors in the absence of Aplnr function.</p></sec><sec id="s2-4"><title>Loss of aplnr leads to a delay in <italic>mesp</italic> expression</title><p>We next assessed how a reduction in Nodal signaling may cause a delay in mesendodermal ingression during gastrulation. Previous work has shown that Nodal target genes become activated depending on the dose and/or associated time of exposure to the Nodal ligand (<xref ref-type="bibr" rid="bib22">Hagos and Dougan, 2007</xref>). We hypothesized that Aplnr may be required to boost the Nodal signal in order to activate the expression of genes required for ingression at the right time. A particularly interesting category of genes that were down-regulated in the double <italic>aplnra/b</italic> morphant microarray was the <italic>mesp</italic> family of transcription factors (<xref ref-type="supplementary-material" rid="SD1-data">Figure 4—source data 1</xref>). In mice, <italic>Mesp1/2</italic> have been shown to regulate the migration of mesoderm through the primitive streak during gastrulation and are essential for cardiac formation (<xref ref-type="bibr" rid="bib31">Kitajima et al., 2000</xref>). Treatment of 4.5–55-5.25 hpf WT embryos with Nodal inhibitor SB505124 completely abrogated <italic>mespaa</italic> and <italic>mespab</italic> expression (<xref ref-type="fig" rid="fig4">Figure 4A</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). In addition, animal cap transplants of <italic>sqt</italic>-overexpressing cells induced <italic>mespaa/mespab</italic> expression, demonstrating that <italic>mesp</italic> genes are <italic>bona fide</italic> Nodal targets (<xref ref-type="fig" rid="fig4">Figure 4B</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). By WISH, we confirmed that both <italic>mespaa</italic> and <italic>mespab</italic> are expressed around the margin during gastrulation (<xref ref-type="bibr" rid="bib13">Cutty et al., 2012</xref>; <xref ref-type="bibr" rid="bib46">Sawada et al., 2000</xref>) and that their expression is dramatically decreased in <italic>aplnra/b</italic> morphant embryos at 50% epiboly (5.25 hpf, <xref ref-type="fig" rid="fig4">Figure 4C–D and G–H</xref>). By carefully examining the expression pattern of <italic>mespaa/ab</italic> throughout development in WT and <italic>aplnra/b</italic> morphants, we found that at shield stage (6 hpf, 45 min after 50% epiboly) expression of both <italic>mespaa</italic> and <italic>mespab</italic> appeared to largely recover in <italic>aplnra/b</italic> morphant embryos (<xref ref-type="fig" rid="fig4">Figure 4E–F and I–J</xref>). Embryos at both stages were stage matched based on morphology, arguing against a general developmental delay as the cause of this phenotype. This demonstrates that Aplnr is required for timely activation of <italic>mesp</italic> genes and that the loss of Aplnr results in a delay in activation, rather than a general attenuation of Nodal target gene expression.<fig-group><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.13758.010</object-id><label>Figure 4.</label><caption><title>Loss of aplnr results in a delay in <italic>mesp</italic> gene expression and the attenuation of Sqt and Cyc activity in a non-cell autonomous manner by aplnr.</title><p>(<bold>A</bold>) Animal view of <italic>mespaa</italic> expression at 50% epiboly (5.25 hpf) in embryos treated with 10 μM of SB505124 from 4–5.25 hpf. Animal cap view with dorsal to the bottom. (<bold>B</bold>) Animal view of <italic>mespaa</italic> expression at 50% epiboly (5.25 hpf) in embryos in which cells expressing 4 pg of <italic>sqt</italic> RNA were transplanted into the animal cap. Animal cap view with dorsal to the bottom. (<bold>C–J</bold>) Expression of <italic>mespaa</italic> and <italic>mespab</italic> at 50% epiboly (5.3 hpf) (<bold>C</bold>,<bold>D</bold>,<bold>G</bold>,<bold>H</bold>) and the shield stage (6 hpf) (<bold>E</bold>,<bold>F</bold>,<bold>I</bold>,<bold>J</bold>) in WT and <italic>aplnra/b</italic> morphant embryos when examined by WISH. Embryos are viewed from the animal pole with dorsal at the bottom. (K) Animal cap transplant of GFP expressing control cells detected by WISH. (<bold>L–T</bold>) Animal cap transplants of <italic>sqt</italic> or <italic>cyc</italic> overexpressing cells into WT (<bold>L–O</bold>) or <italic>aplnra/b</italic> morphant embryos (<bold>P–S</bold>) at 5.5 hpf. <italic>gsc</italic> and <italic>ntl</italic> expression is displayed in blue and <italic>gfp</italic> expressing donor cells are marked in brown. Both donor cells and hosts are of the same background (WT into WT or morphant into morphant). Embryos are viewed from the animal pole with dorsal at the bottom. Data are represented as means ± SEM. (<bold>U–X</bold>) Animal cap transplants of cells expressing high levels of <italic>sqt</italic> RNA at 5.5 hpf. <italic>ntl</italic> expression is visualized in blue and <italic>gfp</italic> expressing donor cells are brown. Four different combinations of donor/host cells were examined, WT into WT (donor into host) (<bold>U</bold>), <italic>aplnra/b</italic> morphant into WT (<bold>V</bold>), WT into <italic>aplnra/b</italic> morphant (<bold>W</bold>) and <italic>aplnra/b</italic> morphant into morphant (<bold>X</bold>). Donor cells are circled in white. Embryos are viewed from the animal pole with dorsal at the bottom.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13758.010">http://dx.doi.org/10.7554/eLife.13758.010</ext-link></p><p><supplementary-material id="SD1-data"><object-id pub-id-type="doi">10.7554/eLife.13758.011</object-id><label>Figure 4—source data 1.</label><caption><title>Microarray data for <italic>mesp</italic> family genes on <italic>aplnra/b</italic> morphant array.</title><p>Fold change for all <italic>mesp</italic> family probes present on the microarray. Fold change is comparing WT to <italic>aplnra/b</italic> morphant embryos from normalized data from four biological replicates.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13758.011">http://dx.doi.org/10.7554/eLife.13758.011</ext-link></p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-13758-fig4-data1-v2.docx"/></supplementary-material></p></caption><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-13758-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.13758.012</object-id><label>Figure 4—figure supplement 1.</label><caption><title><italic>mespaa</italic> and <italic>mespab</italic> are Nodal target genes and Nodal ligand expression is not affected in <italic>aplnra/b</italic> morphant embryos.</title><p>(<bold>A</bold>) Animal view of <italic>mespab</italic> expression at 50% epiboly (5.25 hpf) in embryos treated with 10 μM of SB505124 from 4–5.25 hpf. Animal cap view with dorsal to the bottom. (<bold>B</bold>) Animal view of <italic>mespab</italic> expression at 50% epiboly (5.25 hpf) in embryos in which cells expressing 4 pg of <italic>sqt</italic> RNA were transplanted into the animal cap. Animal cap view with dorsal to the bottom. (<bold>C–N</bold>) Lateral view of the Nodal ligands <italic>sqt</italic> (<bold>C–H</bold>) and <italic>cyc</italic> (<bold>I–N</bold>) expression at sphere (4 hpf), 30% epiboly (4.7 hpf) and 50% epiboly (5.25 hpf) in WT and <italic>aplnra/b</italic> morphant embryos.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13758.012">http://dx.doi.org/10.7554/eLife.13758.012</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-13758-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.13758.013</object-id><label>Figure 4—figure supplement 2.</label><caption><title>Aplnr is required to enhance Nodal signaling for proper cardiac development.</title><p>(<bold>A–B</bold>) Model for the Nodal-mediated nature of the Aplnr phenotype. In WT embryos, Aplnr is required for the appropriate Nodal threshold to be reached in order to initiate the expression of the downstream transcriptional program to drive the ingression of cardiac progenitors and their migration towards the anterior of the embryo. Threshold refers to the integrated level of Nodal signaling that a cell is required to receive in order to activate this program. In <italic>aplnr</italic> mutant embryos it takes a longer period of time in order for this threshold to be reached and results in a delay in gene expression and ingression of the mesendoderm. As a result cardiac progenitors are unable to migrate all the way to the heart forming regions. Red circle denotes the location of cardiac progenitors in the embryo. (<bold>C–D</bold>) Model for the autonomy of Aplnr function in the context of regulating Nodal signaling. Aplnr appears to be required not in Nodal secreting cells or the cardiac progenitor cells receiving the signal, but instead in the surrounding environment. This role is important for the activation of the transcriptional program required for development of cardiac progenitor cells (CPCs). In the absence of Aplnr, the Nodal signal received by the cardiac progenitor is diminished (demonstrated by a reduction in the colour of the green Nodal ligands). This may reflect improper ligand processing or activity.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13758.013">http://dx.doi.org/10.7554/eLife.13758.013</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-13758-fig4-figsupp2-v2.tif"/></fig></fig-group></p></sec><sec id="s2-5"><title>Loss of aplnr reduces activity of Nodal ligands in a non-cell autonomous manner</title><p>We next sought to determine if Aplnr might directly act on the Nodal signaling pathway. An examination by WISH revealed that in <italic>aplnra/b</italic> morphants <italic>cyc</italic> and <italic>sqt</italic> expression appeared increased at 4 hpf, and normal at 4.7–5.3 hpf (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C–N</xref>), suggesting that attenuated Nodal signaling was not a consequence of reduced ligand expression. To address possible effects of Aplnr on Nodal signal transduction, we took advantage of a previously developed zebrafish Nodal point source assay (<xref ref-type="bibr" rid="bib11">Chen and Schier, 2001</xref>). Nodal overexpressing cells were transplanted into the animal cap of host embryos and the ability to induce target genes was subsequently evaluated (<xref ref-type="fig" rid="fig4">Figure 4K</xref>). While in WT (WT host and donor) embryos 4 pg of <italic>sqt</italic> RNA was found to be sufficient to induce <italic>gsc</italic> expression, this dose was not sufficient to achieve <italic>gsc</italic> induction in <italic>aplnra/b</italic> morphant (host and donor) embryos (<xref ref-type="fig" rid="fig4">Figure 4L,P and T</xref>). To evaluate if this was a complete loss of Sqt activity or simply a reduction, we looked at the ability to induce the low threshold Nodal target gene <italic>ntl</italic> (<xref ref-type="bibr" rid="bib11">Chen and Schier, 2001</xref>). In contrast to <italic>gsc, ntl</italic> expression was induced at a high frequency in both WT and morphant embryos, demonstrating that the loss of Aplnr resulted in an attenuation but not a complete loss of Sqt activity (<xref ref-type="fig" rid="fig4">Figure 4M,Q and T</xref>). Similarly, 20 pg of <italic>cyc</italic> RNA was less effective at inducing both <italic>gsc</italic> and <italic>ntl</italic> in <italic>aplnra/b</italic> morphant embryos, suggesting that Aplnra/b regulates the activity of both Nodal ligands (<xref ref-type="fig" rid="fig4">Figure 4N–O, R–S and T</xref>).</p><p>To investigate whether Aplnr is required cell autonomously for its effect on Nodal signaling a further series of transplantation experiments were conducted. For these experiments, a higher dose of <italic>sqt</italic> RNA (40 pg) was injected in donor embryos, which when transplanted into recipient embryos induced a ring of <italic>ntl</italic> expression in the host cells surrounding the donor cells (<xref ref-type="fig" rid="fig4">Figure 4U</xref>, donor cells are encircled). While both WT and <italic>aplnra/b</italic> morphant donor cells induced a strong ring of <italic>ntl</italic> expression when transplanted into WT host embryos, a significantly smaller expression domain was induced when these cells were transplanted into <italic>aplnra/b</italic> morphant host embryos (<xref ref-type="fig" rid="fig4">Figure 4V–X</xref>). This suggests that Aplnra/b activity is not strictly required in Nodal secreting cells for proper Nodal signaling.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study we demonstrate that the endoderm and cardiac defects in zebrafish lacking <italic>aplnr</italic> can be attributed to decreased Nodal signaling. We propose a model where Aplnr activity enhances the effect of Nodal signaling that allows for a Nodal threshold to be met at the right time in order to induce the expression of genes required for ingression of lateral marginal cells and proper heart formation. In the absence of <italic>aplnr</italic> function, a longer time frame is required for cells to reach this threshold of Nodal signaling, resulting in a delay in internalization (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A–B</xref>). These results are consistent with our previous observations on both the non-cell autonomous and temporal roles of Aplnr signaling in cardiac specification (<xref ref-type="bibr" rid="bib48">Scott et al., 2007</xref>; <xref ref-type="bibr" rid="bib40">Paskaradevan and Scott, 2012</xref>). Our conclusion on a Nodal-mediated effect of Aplnr is based on several lines of evidence in <italic>aplnra/b</italic> double mutants and morphants: 1) many classic Nodal target genes are downregulated; 2) ARE:Luciferase activity, a direct readout of Nodal input, is reduced; 3) sensitivity to Nodal inhibitor and lower Oep levels; 4) rescue of the phenotype by increased Nodal signal (<italic>tar*</italic> and <italic>lefty</italic> MO rescue); and 5) reduced effect of Sqt and Cyc point sources.</p><sec id="s3-1"><title>Aplnr: A rheostat for Nodal signaling</title><p>The link between the Aplnr defect and Nodal signaling fits well into the context of previously published literature. Nodal signaling establishes the mesendoderm and a loss of Nodal signaling or its downstream transcriptional effectors results in a heartless phenotype (<xref ref-type="bibr" rid="bib18">Feldman et al., 2000</xref>; <xref ref-type="bibr" rid="bib33">Kunwar et al., 2003</xref>). Furthermore, cells lacking the functional Nodal co-receptor <italic>oep</italic> are unable to internalize during gastrulation and cannot contribute to the mesoderm or endoderm (<xref ref-type="bibr" rid="bib8">Carmany-Rampey and Schier, 2001</xref>). These cells stay at the margin and continue to move towards the vegetal pole. Likewise, <italic>aplnra/b</italic> morphant cells display delayed ingression kinetics that do not support proper cardiac development (<xref ref-type="bibr" rid="bib40">Paskaradevan and Scott, 2012</xref>). However, unlike the loss of Oep, loss of Aplnr results in a partial and not total loss of Nodal activity, and mesendodermal ingression is evident, albeit at a later time. This also provides a plausible explanation for the incomplete penetrance of the cardiac phenotype observed in <italic>aplnra</italic> and <italic>aplnrb</italic> mutant embryos (<xref ref-type="bibr" rid="bib48">Scott et al., 2007</xref>; <xref ref-type="bibr" rid="bib12">Chng et al., 2013</xref>). In mouse embryonic stem cells, graded Nodal signaling over 18 hr regulates differentiation to mesendodermal fates, with very subtle (two-fold) changes in levels of phospho-Smads having profound effects (<xref ref-type="bibr" rid="bib34">Lee et al., 2011</xref>). As gastrulation proceeds far more quickly in zebrafish than it does in mice, this may also explain why profound cardiogenesis defects are not frequently seen in <italic>Aplnr/Apj</italic> mutant mice (<xref ref-type="bibr" rid="bib27">Kang et al., 2013</xref>).</p><p>Our report of the targeted genetic knockout of zebrafish <italic>aplnra</italic> supports the notion that both paralogues fulfil a common role during cardiogenesis. In contrast to previous work with <italic>aplnra</italic> MOs (<xref ref-type="bibr" rid="bib37">Nornes et al., 2009</xref>), we find that <italic>aplnra</italic> mutants do not have epiboly defects, but rather only share features of the <italic>aplnrb<sup>grinch/hu4145</sup> </italic>cardiac and endoderm phenotypes. As loss of either <italic>aplnra</italic> or <italic>aplnrb</italic> can have effects on cardiac progenitor specification, we hypothesize that both act in concert to modulate Nodal signaling, with loss of either potentially resulting in a sufficient decrease to impinge on cardiogenesis.</p><p>It has been previously demonstrated that distinct Nodal target genes require different Nodal activity thresholds for activation (<xref ref-type="bibr" rid="bib11">Chen and Schier, 2001</xref>; <xref ref-type="bibr" rid="bib34">Lee et al., 2011</xref>). The level of Nodal signal that a cell perceives depends on both the concentration and duration of the signal (<xref ref-type="bibr" rid="bib22">Hagos and Dougan, 2007</xref>; <xref ref-type="bibr" rid="bib17">Dubrulle et al., 2015</xref>). In <italic>aplnr</italic> mutants, given the reduction in Nodal signaling, marginal cells likely require a longer exposure to Nodal ligands before a certain threshold is reached to induce migration and <italic>mesp</italic> expression. This may explain why endodermal progenitors do eventually migrate and why <italic>mesp</italic> expression recovers in <italic>aplnr</italic> morphant embryos. In support of this hypothesis, <italic>mesp</italic> expression in <italic>aplnr</italic> morphant embryos at 50% epiboly appears to be retained in the most marginal blastomeres, consistent with the fact that these blastomeres are closest to the source of Nodal ligand. The basic helix-loop-helix Mesp transcription factor family has been shown to regulate the migration of mesoderm through the primitive streak in mice, and play key roles in cardiac development in several contexts (<xref ref-type="bibr" rid="bib31">Kitajima et al., 2000</xref>; <xref ref-type="bibr" rid="bib44">Saga et al., 1999</xref>; <xref ref-type="bibr" rid="bib45">Satou et al., 2004</xref>; <xref ref-type="bibr" rid="bib7">Bondue et al., 2008</xref>). This provides a molecular mechanism for how reduced levels of Nodal may translate into a delay of cell movement during gastrulation. However, we do not believe that defects in <italic>mesp</italic> expression can fully account for the <italic>aplnr</italic> cardiac phenotype. In our hands, <italic>mespaa</italic> overexpression was not sufficient to rescue cardiogenesis in <italic>aplnr</italic> morphants or mutants (A.R.D. and I.C.S., unpublished results). On the other hand, finer temporal expression of <italic>mesp</italic> expression may be required for proper cardiac specification.</p></sec><sec id="s3-2"><title>The nature of the aplnr effect on Nodal signaling</title><p>The cellular autonomy of Aplnr function in cardiac progenitor development has been an area of confusion, notably as both cell autonomous (<xref ref-type="bibr" rid="bib48">Scott et al., 2007</xref>; <xref ref-type="bibr" rid="bib57">Zeng et al., 2007</xref>) and non-autonomous (<xref ref-type="bibr" rid="bib40">Paskaradevan and Scott, 2012</xref>) roles have been documented. Our results clearly show that Aplnr is not absolutely required in cells expressing Nodal ligands for signaling activity (<xref ref-type="fig" rid="fig4">Figures 4U–X</xref>), arguing against a model where Aplnr affects ligand secretion. Given that our previous experiments suggest that the Aplnr is also not required in cardiac progenitors themselves, we do not favour a model where Aplnr is required cell autonomously for reception or readout of the Nodal signal. It is possible that rather than playing a strictly cell autonomous (in cardiac progenitors) or non-autonomous (in Nodal signal sending cells) role, a threshold level of Aplnr activity is required in cells surrounding cardiac progenitors to ensure that proper levels of Nodal signaling can take place (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2C–D</xref>). This model helps explain previous conflicting results, in which <italic>aplnra/b</italic> morphant donor cells typically have a reduced, but not completely absent, ability to develop as cardiomyocytes (<xref ref-type="bibr" rid="bib48">Scott et al., 2007</xref>; <xref ref-type="bibr" rid="bib40">Paskaradevan and Scott, 2012</xref>). It may be that in cases where a larger donor clone lacking Aplnr function is assayed, many cells inside the clone (encompassing both cardiac progenitors and other cells) do not receive the proper Nodal signal for cardiogenesis. Aplnr signaling may act, for example, to regulate Nodal ligand processing or activity, which has been shown to occur extracellularly (<xref ref-type="bibr" rid="bib5">Beck et al., 2002</xref>). The interpretation of transplant experiments may therefore be confounded by the size of donor tissue. The role of a “community effect” in amplifying the Nodal signal to drive collective epithelial-to-mesenchymal transition during gastrulation has recently been described (<xref ref-type="bibr" rid="bib54">Voiculescu et al., 2014</xref>). As Aplnr is both activated by Nodal (at the level of gene expression) and in turn potentiates Nodal signaling, this may provide a feed-forward mechanism to help achieve maximal Nodal signaling for proper gastrulation in a timely manner. Mechanistically, how Aplnr activity impinges on the Nodal pathway remains to be determined. Signaling cascades downstream of Aplnr, both G protein-dependent and -independent, have been described (reviewed in (<xref ref-type="bibr" rid="bib9">Chapman et al., 2014</xref>; <xref ref-type="bibr" rid="bib38">O'Carroll et al., 2013</xref>). Which of these are required for Aplnr function in cardiac development, or if a new pathway is involved, remains to be elucidated. How signaling at the level of the Aplnr happens in the context of early gastrulation also remains unknown. Numerous studies have described roles for the classical Apelin/Aplnr hormone GPCR (G-protein Coupled Receptor) signaling pair in adult physiology, however in the context of early heart development Apelin does not appear to be the correct Aplnr ligand (<xref ref-type="bibr" rid="bib48">Scott et al., 2007</xref>; <xref ref-type="bibr" rid="bib12">Chng et al., 2013</xref>; <xref ref-type="bibr" rid="bib4">Ashley et al., 2005</xref>; <xref ref-type="bibr" rid="bib32">Kuba et al., 2007</xref>; <xref ref-type="bibr" rid="bib50">Szokodi et al., 2002</xref>). This has been confirmed by the recent discovery of a second small endogenous peptide ligand for Aplnr, Elabela (<ext-link ext-link-type="uri" xlink:href="www.elabela.com">www.elabela.com</ext-link>), whose mutation also results in loss of cardiac differentiation in zebrafish (<xref ref-type="bibr" rid="bib41">Pauli et al., 2014</xref>; <xref ref-type="bibr" rid="bib12">Chng et al., 2013</xref>) and mice (unpublished results L.H and B.R). How these two ligands may fit into the Aplnr regulation of Nodal remains an intriguing area for future investigation.</p></sec><sec id="s3-3"><title>Perspectives</title><p>In conclusion, we find that Aplnr is required to enhance Nodal signaling in order to activate genes required for proper cell movement and consequently cardiac development at the right time. This work opens several lines of future investigation on the early events required for the movement of the mesendoderm during gastrulation and early cardiac progenitor development. The levels and timing of key signaling pathways such as Nodal/TGFβ are essential to developmental output, as can be measured during differentiation of pluripotent stem cells in culture (<xref ref-type="bibr" rid="bib28">Kattman et al., 2011</xref>). Similar mechanisms to that described here for Aplnr signaling may therefore remain to be discovered for other major developmental pathways. As to why lateral populations are specifically affected in <italic>aplnra/b</italic> mutants and not dorsal ones, where Nodal signaling is particularly prevalent, we speculate that the levels of Nodal modulated by Aplnr will not have as large a consequence in a high Nodal signaling environment like the shield/dorsal aspect of the embryo. Furthermore, only <italic>aplnra</italic> and not <italic>aplnrb</italic> is expressed in the dorsal part of the embryo (<xref ref-type="bibr" rid="bib53">Tucker et al., 2007</xref>). Further, given that Aplnr signaling has been shown to regulate multiple aspects of adult physiology (reviewed in (<xref ref-type="bibr" rid="bib9">Chapman et al., 2014</xref>; <xref ref-type="bibr" rid="bib38">O'Carroll et al., 2013</xref>), the role of this novel signaling mechanism and the potential functions of Elabela and/or Apelin in the context of physiological homeostasis and disease (<xref ref-type="bibr" rid="bib23">Ho et al., 2015</xref>; <xref ref-type="bibr" rid="bib35">Murza et al., 2016</xref>) are areas of great interest.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Zebrafish mutants, lines and imaging</title><p>Zebrafish were housed and handled as per Canadian Council on Animal Care and Hospital for Sick Children Laboratory Animal Services guidelines. Zebrafish embryos were raised at 28 degrees Celsius according to standard techniques (<xref ref-type="bibr" rid="bib55">Westerfield and Book, 1993</xref>). The <italic>Tg(myl7:EGFP)<sup>twu34</sup></italic> line and <italic>aplnrb<sup>s608</sup> </italic>(<italic>grinch</italic>, p.W90L) mutants have been previously described (<xref ref-type="bibr" rid="bib48">Scott et al., 2007</xref>; <xref ref-type="bibr" rid="bib12">Chng et al., 2013</xref>; <xref ref-type="bibr" rid="bib25">Huang et al., 2003</xref>). <italic>aplnrb<sup>hu4145</sup></italic> (p.W54X) fish were a gift from Stefan Schulte-Merker. In the <italic>aplnrb<sup>hu4145</sup></italic>allele a STOP codon is introduced at the 54<sup>th</sup> amino acid, resulting in a severely truncated protein with no predicted function. A loss-of-function <italic>aplnra<sup>max</sup></italic> mutant line was generated with TALEN pairs purchased from ToolGen (South Korea). The TALEN-binding sites are as follows: 5’ TACACCGAGACATACGATTA 3’ and 5’ TCACACCCAGAGTCATTATA 3’. An additional <italic>aplnra<sup>ins</sup></italic>mutant allele was purchased from Znomics, Inc. (Portland, OR). <italic>aplnra<sup>ZM00177433Tg</sup> </italic>has a (c.886_887insTg(ZM)) retroviral insertion (<xref ref-type="bibr" rid="bib3">Amsterdam and Hopkins, 2006</xref>) that disrupts the ORF of the single coding exon. Imaging was performed using a Leica DFC320 camera on a Leica M205FA stereomicroscope.</p></sec><sec id="s4-2"><title>Genotyping of mutants</title><p>In the <italic>aplnrb<sup>hu4145</sup></italic> mutant allele a premature stop codon has been induced into the coding sequence at amino acid position 54. Primers used for genotyping are used to amplify a 215 bp product which when cut with AciI yields fragments of 140 bp, 52 bp and 25 bp, the mutant allele will not be cut with AciI. Forward primer: CATCTTCATCCTGGGACTCACTG Reverse primer: AGCACCACATAGCTGCTGATCTT. For genotyping the allele of <italic>aplnrb <sup>grinch</sup></italic> the same primers were used as for the <italic>hu4145</italic> allele, but the resultant PCR product was instead cut with EaeI, generating a 141 bp of the 215 bp product in the mutant allele. Genotyping the <italic>aplnra<sup>ZM00177433Tg</sup> </italic>allele was performed using the following primers to detect the presence of the insertion: Forward primer: ACCCTGGAAACATCTGATGGTTC; Reverse primer: AACGGATTGAGGCAGCTGTTGAC. To determine the presence of the WT <italic>aplnra</italic> allele the following forward primer is used instead: Forward primer: CTCGGGTTTCTTCTGCCTTTCCT. Genotyping of the <italic>aplnra<sup>max</sup></italic>allele was performed using the following primers to detect the absence or presence of the deletion. Forward Primer: CGCTTCAGCTTCCAGTGAG; Reverse Primer: ATGTTGACCAGCACCACGTA. To determine for the presence of the WT <italic>aplnra</italic> allele the following forward primer was added: Forward Primer: CACCGAGACATACGATTACTACG. To determine for the presence of the <italic>aplnra<sup>max</sup></italic> allele the following forward primer was added: Forward Primer: CACCGAGACATACGATTACTACTG.</p></sec><sec id="s4-3"><title>Microarrays</title><p>An Agilent zebrafish microarray (V3: 026437) was used to compare the gene expression profile of WT vs <italic>aplnra/b</italic> morphant embryos. 4 replicates were performed and for each experiment 20 embryos were collected at 50% epiboly and total RNA was prepared using the RNAqueous kit (Ambion, Waltham, MA). Microarray results were analyzed using Genespring v11.0.1 (Agilent Technologies, Inc., Santa Clara, CA). As recommended by the manufacturer, the data was normalized using Agilent’s Spatial Detrending Lowess normalization. All data analysis was performed on log2-transformed data. Standard single factor t-tests were used followed by ranking with fold changes. After normalization and averaging the four chips, the data was filtered to remove the probes that showed no signal in order to avoid confounding effects on subsequent analysis (probes below the 20<sup>th</sup> percentile of the distribution of intensities were removed). MIAME-compliant microarray data was submitted to GEO (accession #GSE58683). GSEA was performed with default settings using <italic>aplnra/b</italic> MO-downregulated genes as a custom gene set for comparison against the <italic>sqt</italic> overexpression dataset from #GSE51890.</p></sec><sec id="s4-4"><title>Morpholino and RNA injection</title><p>Embryos were injected at the one cell stage according to standard procedures. Translation blocking MOs against <italic>aplnra</italic> (5’ – cggtgtattccggcgttggctccat – 3’) and <italic>aplnrb</italic> (5’ - agagaagttgtttgtcatgtgctc – 3’) have been previously described (<xref ref-type="bibr" rid="bib48">Scott et al., 2007</xref>). <italic>aplnr</italic> morphant embryos were co-injected with 0.5 ng of <italic>aplnrb</italic> MOs and 1ng of <italic>aplnra</italic> MOs. The translation blocking MOs against <italic>lefty1 (5’ –</italic> cgcggactgaagtcatcttttcaag – 3’) has been previously described (<xref ref-type="bibr" rid="bib20">Feldman et al., 2002</xref>). <italic>lefty1</italic> morphant embryos was injected with 6 ng of MOs per embryo. Translation blocking MOs against <italic>oep</italic> (5’ - gccaataaactccaaaacaactcga – 3’) has been previously described (<xref ref-type="bibr" rid="bib19">Feldman and Stemple, 2001</xref>), with 2.5 ng injected per embryo. In vitro transcribed RNA was prepared using the mMessage Machine Kit (Ambion) and purified using the MegaClear kit (Ambion). 0.5 pg of <italic>tar</italic>* RNA was injected per donor embryo (<xref ref-type="bibr" rid="bib43">Renucci et al., 1996</xref>).</p></sec><sec id="s4-5"><title>Wholemount RNA in situ hybridization</title><p>WISH was carried out using DIG labelled antisense probes as previously described (<xref ref-type="bibr" rid="bib52">Thisse and Thisse, 2008</xref>). Double ISH was performed against a fluorescein-labelled <italic>gfp S65C</italic> probe using previously established protocols (<xref ref-type="bibr" rid="bib58">Zhou et al., 2011</xref>). Fluorescein-labelled probes were detected using INT/BCIP and DIG labelled probes with NBT/BCIP. Probes for <italic>mespaa, mespab, sqt</italic> and <italic>cyc</italic> were prepared from templates containing full length coding sequences. Probes for <italic>myl7, nkx2.5, gsc, sox17, sox32, foxa1, foxa2, foxa3</italic> and <italic>flh</italic> have been previously described (<xref ref-type="bibr" rid="bib30">Kikuchi et al., 2001</xref>; <xref ref-type="bibr" rid="bib47">Schulte-Merker et al., 1994</xref>; <xref ref-type="bibr" rid="bib51">Talbot et al., 1995</xref>; <xref ref-type="bibr" rid="bib10">Chen and Fishman, 1996</xref>; <xref ref-type="bibr" rid="bib2">Alexander et al., 1999</xref>; <xref ref-type="bibr" rid="bib56">Yelon et al., 1999</xref>; <xref ref-type="bibr" rid="bib26">Inohaya et al., 1997</xref>; <xref ref-type="bibr" rid="bib1">Akimenko et al., 1994</xref>; <xref ref-type="bibr" rid="bib39">Odenthal and Nüsslein-Volhard, 1998</xref>). ImageJ analysis software was used to document <italic>sox17</italic> and <italic>sox32</italic> cell numbers and spread.</p></sec><sec id="s4-6"><title>Transplantation</title><p>Transplantation was performed as previously described (<xref ref-type="bibr" rid="bib48">Scott et al., 2007</xref>). Donor embryos were injected with 5% tetramethylrhodamine dextran (10,000 MW, Molecular Probes, Waltham, MA) as a lineage tracer. Transplants were performed by placing 10–20 cells into the margin or animal cap of a host embryo at the sphere stage (4 hpf). For <italic>cyc/sqt</italic> animal cap transplants 200 pg of <italic>gfp S65C</italic> RNA was co-injected into donor embryos. Double ISH was performed to visualize donor cells.</p></sec><sec id="s4-7"><title>Drug treatments</title><p>Nodal inhibition was performed by treating embryos with either SB505124 (10 uM) or SB431542 (Sigma, St. Louis, MO) in egg water/0.1% DMSO. The APLNR agonist ML233 was obtained from Glixx Laboratories Southborough, MA). Embryos were treated with 2.5 μM ML233 in egg water/1% DMSO from the sphere stage onwards.</p></sec><sec id="s4-8"><title>Luciferase assay</title><p>Embryos were injected with 90 pg of ARE3-luc (<xref ref-type="bibr" rid="bib24">Huang et al., 1995</xref>), which contains three copies of the Activin responsive element (ARE), together with 10 pg of CMV-pRL vector (Promega, Madison, WI) at the 1-cell stage. At 30% epiboly, three groups of 20 embryos were lysed with passive lysis buffer (Promega) at room temperature for 20 min. The firefly luciferase activity, normalized to that of Renilla luciferase, was measured using the Dual luciferase assay system (Promega).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We would like to thank all members of the Scott lab for helpful insight and discussion. Special thanks to Angela Morley for excellent zebrafish care and facility maintenance and to Jeff Burrows for generating the model figure. Thanks to Brian Ciruna, Helen McNeill and Freda Miller for helpful discussions and to Norm Rosenblum and the University of Toronto MD/PhD program for support. Thanks to Stefan Schulte-Merker for the <italic>aplnrb<sup>hu4145</sup></italic> allele. ARD was supported by a Canadian Institutes of Health Research Vanier Canada Graduate Scholarship. This work was supported by a grant from the Canadian Institutes of Health Research to ICS (Funding Reference 123223). BR is a fellow of the Branco Weiss Foundation, an A*STAR Investigator and Young EMBO Investigator. This work is funded by a Strategic Positioning Fund on Genetic Orphan Diseases from A*STAR, Singapore.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>ARD, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con2"><p>SCC, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con3"><p>LH, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con4"><p>BR, Conception and design, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con5"><p>ICS, Conception and design, Analysis and interpretation of data, Drafting or revising the article</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Zebrafish were housed and handled as per Canadian Council on Animal Care and Hospital for Sick Children Laboratory Animal Services (LAS) guidelines under LAS protocol number 33584.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><sec id="s7" sec-type="datasets"><title>Major datasets</title><p>The following dataset was generated:</p><p><related-object content-type="generated-dataset" id="data-ro1" source-id="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE58683" source-id-type="uri"><collab>Ashish R Deshwar</collab>, <collab>Ian C Scott</collab><x>,</x> <year>2014</year><x>,</x><source>Data From: The Apelin receptor enhances Nodal/TGFβ signaling to ensure proper cardiac development</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE58683">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE58683</ext-link><x>,</x> <comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE58683).</comment></related-object></p><p>The following previously published dataset was used:</p><p><related-object content-type="generated-dataset" id="data-ro2" source-id="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51890" source-id-type="uri"><collab>Nelson AC</collab>, <collab>Cutty SJ</collab>, <collab>Stemple DL</collab>, <collab>Flicek P</collab>, <collab>Bruce AE</collab>, <collab>Wardle FC</collab><x>,</x> <year>2014</year><x>,</x><source>Expression profiling of control vs. ndr1 overexpression zebrafish blastulas</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51890">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51890</ext-link><x>,</x> <comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE51890)</comment></related-object></p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akimenko</surname><given-names>MA</given-names></name><name><surname>Ekker</surname><given-names>M</given-names></name><name><surname>Wegner</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>W</given-names></name><name><surname>Westerfield</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Combinatorial expression of three zebrafish genes related to distal-less: Part of a homeobox gene code for the head</article-title><source>The Journal of Neuroscience</source><volume>14</volume><fpage>3475</fpage><lpage>3486</lpage></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>J</given-names></name><name><surname>Rothenberg</surname><given-names>M</given-names></name><name><surname>Henry</surname><given-names>GL</given-names></name><name><surname>Stainier</surname><given-names>DY</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>casanova plays an early and essential role in endoderm formation in zebrafish</article-title><source>Developmental Biology</source><volume>215</volume><fpage>343</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1006/dbio.1999.9441</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amsterdam</surname><given-names>A</given-names></name><name><surname>Hopkins</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Mutagenesis strategies in zebrafish for identifying genes involved in development and disease</article-title><source>Trends in Genetics</source><volume>22</volume><fpage>473</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2006.06.011</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashley</surname><given-names>EA</given-names></name><name><surname>Powers</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Kundu</surname><given-names>R</given-names></name><name><surname>Finsterbach</surname><given-names>T</given-names></name><name><surname>Caffarelli</surname><given-names>A</given-names></name><name><surname>Deng</surname><given-names>A</given-names></name><name><surname>Eichhorn</surname><given-names>J</given-names></name><name><surname>Mahajan</surname><given-names>R</given-names></name><name><surname>Agrawal</surname><given-names>R</given-names></name><name><surname>Greve</surname><given-names>J</given-names></name><name><surname>Robbins</surname><given-names>R</given-names></name><name><surname>Patterson</surname><given-names>AJ</given-names></name><name><surname>Bernstein</surname><given-names>D</given-names></name><name><surname>Quertermous</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo</article-title><source>Cardiovascular Research</source><volume>65</volume><fpage>73</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2004.08.018</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>S</given-names></name><name><surname>Le Good</surname><given-names>JA</given-names></name><name><surname>Guzman</surname><given-names>M</given-names></name><name><surname>Ben Haim</surname><given-names>N</given-names></name><name><surname>Roy</surname><given-names>K</given-names></name><name><surname>Beermann</surname><given-names>F</given-names></name><name><surname>Constam</surname><given-names>DB</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Extraembryonic proteases regulate nodal signalling during gastrulation</article-title><source>Nature Cell Biology</source><volume>4</volume><fpage>981</fpage><lpage>985</lpage><pub-id pub-id-type="doi">10.1038/ncb890</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>JT</given-names></name><name><surname>Joubin</surname><given-names>K</given-names></name><name><surname>Cheng</surname><given-names>S</given-names></name><name><surname>Aanstad</surname><given-names>P</given-names></name><name><surname>Herwig</surname><given-names>R</given-names></name><name><surname>Clark</surname><given-names>M</given-names></name><name><surname>Lehrach</surname><given-names>H</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Nodal signaling activates differentiation genes during zebrafish gastrulation</article-title><source>Developmental Biology</source><volume>304</volume><fpage>525</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2007.01.012</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bondue</surname><given-names>A</given-names></name><name><surname>Lapouge</surname><given-names>G</given-names></name><name><surname>Paulissen</surname><given-names>C</given-names></name><name><surname>Semeraro</surname><given-names>C</given-names></name><name><surname>Iacovino</surname><given-names>M</given-names></name><name><surname>Kyba</surname><given-names>M</given-names></name><name><surname>Blanpain</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification</article-title><source>Cell Stem Cell</source><volume>3</volume><fpage>69</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2008.06.009</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmany-Rampey</surname><given-names>A</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Single-cell internalization during zebrafish gastrulation</article-title><source>Current Biology</source><volume>11</volume><fpage>1261</fpage><lpage>1265</lpage><pub-id pub-id-type="doi">10.1016/s0960-9822(01)00353-0</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname><given-names>NA</given-names></name><name><surname>Dupré</surname><given-names>DJ</given-names></name><name><surname>Rainey</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The apelin receptor: Physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR</article-title><source>Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire</source><volume>92</volume><fpage>431</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1139/bcb-2014-0072</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>JN</given-names></name><name><surname>Fishman</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Zebrafish tinman homolog demarcates the heart field and initiates myocardial differentiation</article-title><source>Development</source><volume>122</volume><fpage>3809</fpage><lpage>3816</lpage></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The zebrafish nodal signal squint functions as a morphogen</article-title><source>Nature</source><volume>411</volume><fpage>607</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1038/35079121</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chng</surname><given-names>SC</given-names></name><name><surname>Ho</surname><given-names>L</given-names></name><name><surname>Tian</surname><given-names>J</given-names></name><name><surname>Reversade</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Elabela: A hormone essential for heart development signals via the apelin receptor</article-title><source>Developmental Cell</source><volume>27</volume><fpage>672</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2013.11.002</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutty</surname><given-names>SJ</given-names></name><name><surname>Fior</surname><given-names>R</given-names></name><name><surname>Henriques</surname><given-names>PM</given-names></name><name><surname>Saúde</surname><given-names>L</given-names></name><name><surname>Wardle</surname><given-names>FC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Identification and expression analysis of two novel members of the mesp family in zebrafish</article-title><source>The International Journal of Developmental Biology</source><volume>56</volume><fpage>285</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1387/ijdb.113447sc</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Aniello</surname><given-names>C</given-names></name><name><surname>Lonardo</surname><given-names>E</given-names></name><name><surname>Iaconis</surname><given-names>S</given-names></name><name><surname>Guardiola</surname><given-names>O</given-names></name><name><surname>Liguoro</surname><given-names>AM</given-names></name><name><surname>Liguori</surname><given-names>GL</given-names></name><name><surname>Autiero</surname><given-names>M</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name><name><surname>Minchiotti</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>G protein-coupled receptor APJ and its ligand apelin act downstream of cripto to specify embryonic stem cells toward the cardiac lineage through extracellular signal-regulated kinase/p70s6 kinase signaling pathway</article-title><source>Circulation Research</source><volume>105</volume><fpage>231</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.201186</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Aniello</surname><given-names>C</given-names></name><name><surname>Fiorenzano</surname><given-names>A</given-names></name><name><surname>Iaconis</surname><given-names>S</given-names></name><name><surname>Liguori</surname><given-names>GL</given-names></name><name><surname>Andolfi</surname><given-names>G</given-names></name><name><surname>Cobellis</surname><given-names>G</given-names></name><name><surname>Fico</surname><given-names>A</given-names></name><name><surname>Minchiotti</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The g-protein-coupled receptor APJ is expressed in the second heart field and regulates cerberus-baf60c axis in embryonic stem cell cardiomyogenesis</article-title><source>Cardiovascular Research</source><volume>100</volume><fpage>95</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvt166</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dougan</surname><given-names>ST</given-names></name><name><surname>Warga</surname><given-names>RM</given-names></name><name><surname>Kane</surname><given-names>DA</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name><name><surname>Talbot</surname><given-names>WS</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The role of the zebrafish nodal-related genes squint and cyclops in patterning of mesendoderm</article-title><source>Development</source><volume>130</volume><fpage>1837</fpage><lpage>1851</lpage><pub-id pub-id-type="doi">10.1242/dev.00400</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubrulle</surname><given-names>J</given-names></name><name><surname>Jordan</surname><given-names>BM</given-names></name><name><surname>Akhmetova</surname><given-names>L</given-names></name><name><surname>Farrell</surname><given-names>JA</given-names></name><name><surname>Kim</surname><given-names>S-H</given-names></name><name><surname>Solnica-Krezel</surname><given-names>L</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Response to nodal morphogen gradient is determined by the kinetics of target gene induction</article-title><source>eLife</source><volume>4</volume><elocation-id>e05042</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.05042</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldman</surname><given-names>B</given-names></name><name><surname>Dougan</surname><given-names>ST</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name><name><surname>Talbot</surname><given-names>WS</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Nodal-related signals establish mesendodermal fate and trunk neural identity in zebrafish</article-title><source>Current Biology</source><volume>10</volume><fpage>531</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1016/s0960-9822(00)00469-3</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldman</surname><given-names>B</given-names></name><name><surname>Stemple</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Morpholino phenocopies of sqt, oep, and ntl mutations</article-title><source>Genesis</source><volume>30</volume><fpage>175</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1002/gene.1058</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldman</surname><given-names>B</given-names></name><name><surname>Concha</surname><given-names>ML</given-names></name><name><surname>Saúde</surname><given-names>L</given-names></name><name><surname>Parsons</surname><given-names>MJ</given-names></name><name><surname>Adams</surname><given-names>RJ</given-names></name><name><surname>Wilson</surname><given-names>SW</given-names></name><name><surname>Stemple</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Lefty antagonism of squint is essential for normal gastrulation</article-title><source>Current Biology</source><volume>12</volume><fpage>2129</fpage><lpage>2135</lpage><pub-id pub-id-type="doi">10.1016/s0960-9822(02)01361-1</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gritsman</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>S</given-names></name><name><surname>Heckscher</surname><given-names>E</given-names></name><name><surname>Talbot</surname><given-names>WS</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The EGF-CFC protein one-eyed pinhead is essential for nodal signaling</article-title><source>Cell</source><volume>97</volume><fpage>121</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)80720-5</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagos</surname><given-names>EG</given-names></name><name><surname>Dougan</surname><given-names>ST</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Time-dependent patterning of the mesoderm and endoderm by nodal signals in zebrafish</article-title><source>BMC Developmental Biology</source><volume>7</volume><fpage>22</fpage><pub-id pub-id-type="doi">10.1186/1471-213X-7-22</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>L</given-names></name><name><surname>Tan</surname><given-names>SY</given-names></name><name><surname>Wee</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Tan</surname><given-names>SJ</given-names></name><name><surname>Ramakrishna</surname><given-names>NB</given-names></name><name><surname>Chng</surname><given-names>SC</given-names></name><name><surname>Nama</surname><given-names>S</given-names></name><name><surname>Szczerbinska</surname><given-names>I</given-names></name><name><surname>Sczerbinska</surname><given-names>I</given-names></name><name><surname>Chan</surname><given-names>YS</given-names></name><name><surname>Avery</surname><given-names>S</given-names></name><name><surname>Tsuneyoshi</surname><given-names>N</given-names></name><name><surname>Ng</surname><given-names>HH</given-names></name><name><surname>Gunaratne</surname><given-names>J</given-names></name><name><surname>Dunn</surname><given-names>NR</given-names></name><name><surname>Reversade</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Elabela is an endogenous growth factor that sustains hesc self-renewal via the PI3K/AKT pathway</article-title><source>Cell Stem Cell</source><volume>17</volume><fpage>435</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2015.08.010</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>HC</given-names></name><name><surname>Murtaugh</surname><given-names>LC</given-names></name><name><surname>Vize</surname><given-names>PD</given-names></name><name><surname>Whitman</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Identification of a potential regulator of early transcriptional responses to mesoderm inducers in the frog embryo</article-title><source>The EMBO Journal</source><volume>14</volume><fpage>5965</fpage><lpage>5973</lpage></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>CJ</given-names></name><name><surname>Tu</surname><given-names>CT</given-names></name><name><surname>Hsiao</surname><given-names>CD</given-names></name><name><surname>Hsieh</surname><given-names>FJ</given-names></name><name><surname>Tsai</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Germ-line transmission of a myocardium-specific GFP transgene reveals critical regulatory elements in the cardiac myosin light chain 2 promoter of zebrafish</article-title><source>Developmental Dynamics</source><volume>228</volume><fpage>30</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1002/dvdy.10356</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inohaya</surname><given-names>K</given-names></name><name><surname>Yasumasu</surname><given-names>S</given-names></name><name><surname>Araki</surname><given-names>K</given-names></name><name><surname>Naruse</surname><given-names>K</given-names></name><name><surname>Yamazaki</surname><given-names>K</given-names></name><name><surname>Yasumasu</surname><given-names>I</given-names></name><name><surname>Iuchi</surname><given-names>I</given-names></name><name><surname>Yamagami</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Species-dependent migration of fish hatching gland cells that express astacin-like proteases in common [corrected]</article-title><source>Development, Growth &amp; Differentiation</source><volume>39</volume><fpage>191</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1046/j.1440-169x.1997.t01-1-00007.x</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Anderson</surname><given-names>JP</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Gleim</surname><given-names>SR</given-names></name><name><surname>Kundu</surname><given-names>RK</given-names></name><name><surname>McLean</surname><given-names>DL</given-names></name><name><surname>Kim</surname><given-names>JD</given-names></name><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Jin</surname><given-names>SW</given-names></name><name><surname>Hwa</surname><given-names>J</given-names></name><name><surname>Quertermous</surname><given-names>T</given-names></name><name><surname>Chun</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development</article-title><source>Circulation Research</source><volume>113</volume><fpage>22</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.113.301324</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kattman</surname><given-names>SJ</given-names></name><name><surname>Witty</surname><given-names>AD</given-names></name><name><surname>Gagliardi</surname><given-names>M</given-names></name><name><surname>Dubois</surname><given-names>NC</given-names></name><name><surname>Niapour</surname><given-names>M</given-names></name><name><surname>Hotta</surname><given-names>A</given-names></name><name><surname>Ellis</surname><given-names>J</given-names></name><name><surname>Keller</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines</article-title><source>Cell Stem Cell</source><volume>8</volume><fpage>228</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2010.12.008</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>P</given-names></name><name><surname>Maloney</surname><given-names>PR</given-names></name><name><surname>Hedrick</surname><given-names>M</given-names></name><name><surname>Gosalia</surname><given-names>P</given-names></name><name><surname>Milewski</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Roth</surname><given-names>GP</given-names></name><name><surname>Sergienko</surname><given-names>E</given-names></name><name><surname>Suyama</surname><given-names>E</given-names></name><name><surname>Sugarman</surname><given-names>E</given-names></name><name><surname>Nguyen</surname><given-names>K</given-names></name><name><surname>Mehta</surname><given-names>A</given-names></name><name><surname>Vasile</surname><given-names>S</given-names></name><name><surname>Su Y</surname><given-names>S</given-names></name><name><surname>Shi</surname><given-names>S</given-names></name><name><surname>Stonich</surname><given-names>D</given-names></name><name><surname>Nguyen</surname><given-names>H</given-names></name><name><surname>Zeng</surname><given-names>FY</given-names></name><name><surname>Novo</surname><given-names>AM</given-names></name><name><surname>Vicchiarelli</surname><given-names>M</given-names></name><name><surname>Diwan</surname><given-names>J</given-names></name><name><surname>Chung</surname><given-names>TDY</given-names></name><name><surname>Pinkerton</surname><given-names>AB</given-names></name><name><surname>Smith</surname><given-names>LH</given-names></name></person-group><year iso-8601-date="2011">2011</year><source>Functional Agonists of the Apelin (APJ) Receptor</source><publisher-loc>In</publisher-loc><publisher-name>Probe Reports from the NIH Molecular Libraries Program</publisher-name></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikuchi</surname><given-names>Y</given-names></name><name><surname>Agathon</surname><given-names>A</given-names></name><name><surname>Alexander</surname><given-names>J</given-names></name><name><surname>Thisse</surname><given-names>C</given-names></name><name><surname>Waldron</surname><given-names>S</given-names></name><name><surname>Yelon</surname><given-names>D</given-names></name><name><surname>Thisse</surname><given-names>B</given-names></name><name><surname>Stainier</surname><given-names>DY</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>casanova encodes a novel sox-related protein necessary and sufficient for early endoderm formation in zebrafish</article-title><source>Genes &amp; Development</source><volume>15</volume><fpage>1493</fpage><lpage>1505</lpage><pub-id pub-id-type="doi">10.1101/gad.892301</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitajima</surname><given-names>S</given-names></name><name><surname>Takagi</surname><given-names>A</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Saga</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Mesp1 and mesp2 are essential for the development of cardiac mesoderm</article-title><source>Development</source><volume>127</volume><fpage>3215</fpage><lpage>3226</lpage></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuba</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Imai</surname><given-names>Y</given-names></name><name><surname>Arab</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Maekawa</surname><given-names>Y</given-names></name><name><surname>Leschnik</surname><given-names>M</given-names></name><name><surname>Leibbrandt</surname><given-names>A</given-names></name><name><surname>Markovic</surname><given-names>M</given-names></name><name><surname>Schwaighofer</surname><given-names>J</given-names></name><name><surname>Beetz</surname><given-names>N</given-names></name><name><surname>Musialek</surname><given-names>R</given-names></name><name><surname>Neely</surname><given-names>GG</given-names></name><name><surname>Komnenovic</surname><given-names>V</given-names></name><name><surname>Kolm</surname><given-names>U</given-names></name><name><surname>Metzler</surname><given-names>B</given-names></name><name><surname>Ricci</surname><given-names>R</given-names></name><name><surname>Hara</surname><given-names>H</given-names></name><name><surname>Meixner</surname><given-names>A</given-names></name><name><surname>Nghiem</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Dawood</surname><given-names>F</given-names></name><name><surname>Wong</surname><given-names>KM</given-names></name><name><surname>Sarao</surname><given-names>R</given-names></name><name><surname>Cukerman</surname><given-names>E</given-names></name><name><surname>Kimura</surname><given-names>A</given-names></name><name><surname>Hein</surname><given-names>L</given-names></name><name><surname>Thalhammer</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>PP</given-names></name><name><surname>Penninger</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Impaired heart contractility in apelin gene deficient mice associated with aging and pressure overload</article-title><source>Circulation Research</source><volume>101</volume><elocation-id>e32</elocation-id><lpage>e42</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.107.158659</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunwar</surname><given-names>PS</given-names></name><name><surname>Zimmerman</surname><given-names>S</given-names></name><name><surname>Bennett</surname><given-names>JT</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Whitman</surname><given-names>M</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Mixer/Bon and foxh1/sur have overlapping and divergent roles in nodal signaling and mesendoderm induction</article-title><source>Development</source><volume>130</volume><fpage>5589</fpage><lpage>5599</lpage><pub-id pub-id-type="doi">10.1242/dev.00803</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KL</given-names></name><name><surname>Lim</surname><given-names>SK</given-names></name><name><surname>Orlov</surname><given-names>YL</given-names></name><name><surname>Yit</surname><given-names>LY</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Ang</surname><given-names>LT</given-names></name><name><surname>Poellinger</surname><given-names>L</given-names></name><name><surname>Lim</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Graded nodal/activin signaling titrates conversion of quantitative phospho-smad2 levels into qualitative embryonic stem cell fate decisions</article-title><source>PLoS Genetics</source><volume>7</volume><elocation-id>e1002130</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002130</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murza</surname><given-names>A</given-names></name><name><surname>Sainsily</surname><given-names>X</given-names></name><name><surname>Coquerel</surname><given-names>D</given-names></name><name><surname>Côté</surname><given-names>J</given-names></name><name><surname>Marx</surname><given-names>P</given-names></name><name><surname>Besserer-Offroy</surname><given-names>É</given-names></name><name><surname>Longpré</surname><given-names>JM</given-names></name><name><surname>Lainé</surname><given-names>J</given-names></name><name><surname>Reversade</surname><given-names>B</given-names></name><name><surname>Salvail</surname><given-names>D</given-names></name><name><surname>Leduc</surname><given-names>R</given-names></name><name><surname>Dumaine</surname><given-names>R</given-names></name><name><surname>Lesur</surname><given-names>O</given-names></name><name><surname>Auger-Messier</surname><given-names>M</given-names></name><name><surname>Sarret</surname><given-names>P</given-names></name><name><surname>Marsault</surname><given-names>É</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Discovery and structure-activity relationship of a bioactive fragment of ELABELA that modulates vascular and cardiac functions</article-title><source>Journal of Medicinal Chemistry</source><volume>59</volume><pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b01549</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>AC</given-names></name><name><surname>Cutty</surname><given-names>SJ</given-names></name><name><surname>Niini</surname><given-names>M</given-names></name><name><surname>Stemple</surname><given-names>DL</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name><name><surname>Houart</surname><given-names>C</given-names></name><name><surname>Bruce</surname><given-names>AE</given-names></name><name><surname>Wardle</surname><given-names>FC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Global identification of smad2 and eomesodermin targets in zebrafish identifies a conserved transcriptional network in mesendoderm and a novel role for eomesodermin in repression of ectodermal gene expression</article-title><source>BMC Biology</source><volume>12</volume><fpage>81</fpage><pub-id pub-id-type="doi">10.1186/s12915-014-0081-5</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nornes</surname><given-names>S</given-names></name><name><surname>Tucker</surname><given-names>B</given-names></name><name><surname>Lardelli</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Zebrafish aplnra functions in epiboly</article-title><source>BMC Research Notes</source><volume>2</volume><fpage>231</fpage><pub-id pub-id-type="doi">10.1186/1756-0500-2-231</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Carroll</surname><given-names>AM</given-names></name><name><surname>Lolait</surname><given-names>SJ</given-names></name><name><surname>Harris</surname><given-names>LE</given-names></name><name><surname>Pope</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The apelin receptor APJ: Journey from an orphan to a multifaceted regulator of homeostasis</article-title><source>The Journal of Endocrinology</source><volume>219</volume><fpage>R13</fpage><lpage>R35</lpage><pub-id pub-id-type="doi">10.1530/JOE-13-0227</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odenthal</surname><given-names>J</given-names></name><name><surname>Nüsslein-Volhard</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>fork head domain genes in zebrafish</article-title><source>Development Genes and Evolution</source><volume>208</volume><fpage>245</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1007/s004270050179</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paskaradevan</surname><given-names>S</given-names></name><name><surname>Scott</surname><given-names>IC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The aplnr GPCR regulates myocardial progenitor development via a novel cell-non-autonomous, gα(i/o) protein-independent pathway</article-title><source>Biology Open</source><volume>1</volume><fpage>275</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1242/bio.2012380</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pauli</surname><given-names>A</given-names></name><name><surname>Norris</surname><given-names>ML</given-names></name><name><surname>Valen</surname><given-names>E</given-names></name><name><surname>Chew</surname><given-names>GL</given-names></name><name><surname>Gagnon</surname><given-names>JA</given-names></name><name><surname>Zimmerman</surname><given-names>S</given-names></name><name><surname>Mitchell</surname><given-names>A</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Dubrulle</surname><given-names>J</given-names></name><name><surname>Reyon</surname><given-names>D</given-names></name><name><surname>Tsai</surname><given-names>SQ</given-names></name><name><surname>Joung</surname><given-names>JK</given-names></name><name><surname>Saghatelian</surname><given-names>A</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Toddler: An embryonic signal that promotes cell movement via apelin receptors</article-title><source>Science</source><volume>343</volume><fpage>1248636</fpage><pub-id pub-id-type="doi">10.1126/science.1248636</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rebagliati</surname><given-names>MR</given-names></name><name><surname>Toyama</surname><given-names>R</given-names></name><name><surname>Haffter</surname><given-names>P</given-names></name><name><surname>Dawid</surname><given-names>IB</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>cyclops encodes a nodal-related factor involved in midline signaling</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><volume>95</volume><fpage>9932</fpage><lpage>9937</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.17.9932</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renucci</surname><given-names>A</given-names></name><name><surname>Lemarchandel</surname><given-names>V</given-names></name><name><surname>Rosa</surname><given-names>F</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>An activated form of type I serine/threonine kinase receptor TARAM-A reveals a specific signalling pathway involved in fish head organiser formation</article-title><source>Development</source><volume>122</volume><fpage>3735</fpage><lpage>3743</lpage></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saga</surname><given-names>Y</given-names></name><name><surname>Miyagawa-Tomita</surname><given-names>S</given-names></name><name><surname>Takagi</surname><given-names>A</given-names></name><name><surname>Kitajima</surname><given-names>S</given-names></name><name><surname>Miyazaki</surname><given-names>J</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Mesp1 is expressed in the heart precursor cells and required for the formation of a single heart tube</article-title><source>Development</source><volume>126</volume><fpage>3437</fpage><lpage>3447</lpage></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satou</surname><given-names>Y</given-names></name><name><surname>Imai</surname><given-names>KS</given-names></name><name><surname>Satoh</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The ascidian mesp gene specifies heart precursor cells</article-title><source>Development</source><volume>131</volume><fpage>2533</fpage><lpage>2541</lpage><pub-id pub-id-type="doi">10.1242/dev.01145</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawada</surname><given-names>A</given-names></name><name><surname>Fritz</surname><given-names>A</given-names></name><name><surname>Jiang</surname><given-names>YJ</given-names></name><name><surname>Yamamoto</surname><given-names>A</given-names></name><name><surname>Yamasu</surname><given-names>K</given-names></name><name><surname>Kuroiwa</surname><given-names>A</given-names></name><name><surname>Saga</surname><given-names>Y</given-names></name><name><surname>Takeda</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Zebrafish mesp family genes, mesp-a and mesp-b are segmentally expressed in the presomitic mesoderm, and mesp-b confers the anterior identity to the developing somites</article-title><source>Development</source><volume>127</volume><fpage>1691</fpage><lpage>1702</lpage></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulte-Merker</surname><given-names>S</given-names></name><name><surname>Hammerschmidt</surname><given-names>M</given-names></name><name><surname>Beuchle</surname><given-names>D</given-names></name><name><surname>Cho</surname><given-names>KW</given-names></name><name><surname>De Robertis</surname><given-names>EM</given-names></name><name><surname>Nüsslein-Volhard</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Expression of zebrafish goosecoid and no tail gene products in wild-type and mutant no tail embryos</article-title><source>Development</source><volume>120</volume><fpage>843</fpage><lpage>852</lpage></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>IC</given-names></name><name><surname>Masri</surname><given-names>B</given-names></name><name><surname>D'Amico</surname><given-names>LA</given-names></name><name><surname>Jin</surname><given-names>SW</given-names></name><name><surname>Jungblut</surname><given-names>B</given-names></name><name><surname>Wehman</surname><given-names>AM</given-names></name><name><surname>Baier</surname><given-names>H</given-names></name><name><surname>Audigier</surname><given-names>Y</given-names></name><name><surname>Stainier</surname><given-names>DY</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The g protein-coupled receptor agtrl1b regulates early development of myocardial progenitors</article-title><source>Developmental Cell</source><volume>12</volume><fpage>403</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2007.01.012</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Ebert</surname><given-names>BL</given-names></name><name><surname>Gillette</surname><given-names>MA</given-names></name><name><surname>Paulovich</surname><given-names>A</given-names></name><name><surname>Pomeroy</surname><given-names>SL</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><volume>102</volume><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szokodi</surname><given-names>I</given-names></name><name><surname>Tavi</surname><given-names>P</given-names></name><name><surname>Földes</surname><given-names>G</given-names></name><name><surname>Voutilainen-Myllylä</surname><given-names>S</given-names></name><name><surname>Ilves</surname><given-names>M</given-names></name><name><surname>Tokola</surname><given-names>H</given-names></name><name><surname>Pikkarainen</surname><given-names>S</given-names></name><name><surname>Piuhola</surname><given-names>J</given-names></name><name><surname>Rysä</surname><given-names>J</given-names></name><name><surname>Tóth</surname><given-names>M</given-names></name><name><surname>Ruskoaho</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility</article-title><source>Circulation Research</source><volume>91</volume><fpage>434</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1161/01.res.0000033522.37861.69</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talbot</surname><given-names>WS</given-names></name><name><surname>Trevarrow</surname><given-names>B</given-names></name><name><surname>Halpern</surname><given-names>ME</given-names></name><name><surname>Melby</surname><given-names>AE</given-names></name><name><surname>Farr</surname><given-names>G</given-names></name><name><surname>Postlethwait</surname><given-names>JH</given-names></name><name><surname>Jowett</surname><given-names>T</given-names></name><name><surname>Kimmel</surname><given-names>CB</given-names></name><name><surname>Kimelman</surname><given-names>D</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>A homeobox gene essential for zebrafish notochord development</article-title><source>Nature</source><volume>378</volume><fpage>150</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1038/378150a0</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thisse</surname><given-names>C</given-names></name><name><surname>Thisse</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>High-resolution in situ hybridization to whole-mount zebrafish embryos</article-title><source>Nature Protocols</source><volume>3</volume><fpage>59</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1038/nprot.2007.514</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tucker</surname><given-names>B</given-names></name><name><surname>Hepperle</surname><given-names>C</given-names></name><name><surname>Kortschak</surname><given-names>D</given-names></name><name><surname>Rainbird</surname><given-names>B</given-names></name><name><surname>Wells</surname><given-names>S</given-names></name><name><surname>Oates</surname><given-names>AC</given-names></name><name><surname>Lardelli</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Zebrafish angiotensin II receptor-like 1a (agtrl1a) is expressed in migrating hypoblast, vasculature, and in multiple embryonic epithelia</article-title><source>Gene Expression Patterns : GEP</source><volume>7</volume><fpage>258</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1016/j.modgep.2006.09.006</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voiculescu</surname><given-names>O</given-names></name><name><surname>Bodenstein</surname><given-names>L</given-names></name><name><surname>Lau</surname><given-names>IJ</given-names></name><name><surname>Stern</surname><given-names>CD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Local cell interactions and self-amplifying individual cell ingression drive amniote gastrulation</article-title><source>eLife</source><volume>3</volume><elocation-id>e01817</elocation-id><pub-id pub-id-type="doi">10.7554/elife.01817</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Westerfield</surname><given-names>M</given-names></name><name><surname>Book</surname><given-names>TZ</given-names></name></person-group><year iso-8601-date="1993">1993</year><source>A Guide for the Laboratory Use of Zebrafish Danio (Brachydanio) Rerio</source><edition>2nd ed</edition><publisher-loc>Oregon</publisher-loc><publisher-name>University of Oregon Press</publisher-name></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yelon</surname><given-names>D</given-names></name><name><surname>Horne</surname><given-names>SA</given-names></name><name><surname>Stainier</surname><given-names>DY</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Restricted expression of cardiac myosin genes reveals regulated aspects of heart tube assembly in zebrafish</article-title><source>Developmental Biology</source><volume>214</volume><fpage>23</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1006/dbio.1999.9406</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>XX</given-names></name><name><surname>Wilm</surname><given-names>TP</given-names></name><name><surname>Sepich</surname><given-names>DS</given-names></name><name><surname>Solnica-Krezel</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Apelin and its receptor control heart field formation during zebrafish gastrulation</article-title><source>Developmental Cell</source><volume>12</volume><fpage>391</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2007.01.011</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Cashman</surname><given-names>TJ</given-names></name><name><surname>Nevis</surname><given-names>KR</given-names></name><name><surname>Obregon</surname><given-names>P</given-names></name><name><surname>Carney</surname><given-names>SA</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>A</given-names></name><name><surname>Mosimann</surname><given-names>C</given-names></name><name><surname>Sondalle</surname><given-names>S</given-names></name><name><surname>Peterson</surname><given-names>RE</given-names></name><name><surname>Heideman</surname><given-names>W</given-names></name><name><surname>Burns</surname><given-names>CE</given-names></name><name><surname>Burns</surname><given-names>CG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Latent tgf-β binding protein 3 identifies a second heart field in zebrafish</article-title><source>Nature</source><volume>474</volume><fpage>645</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1038/nature10094</pub-id></element-citation></ref></ref-list></back><sub-article article-type="article-commentary" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.13758.018</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Robertson</surname><given-names>Elizabeth</given-names></name><role>Reviewing editor</role><aff id="aff8"><institution>University of Oxford</institution>, <country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your work entitled &quot;The Apelin receptor enhances Nodal/TGFβ signaling to ensure proper cardiac development&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Sean Morrison as the Senior Editor.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>In general all four reviewers who assessed your manuscript agree that your report represents a significant advance from your previous work in this area and revise current models about the cell autonomous/non-autonomous modes of action of the Apln receptor.</p><p>Central Conclusions:</p><p>Via the use of a novel mutant in combination with morphant analysis the authors show that Apln receptors act redundantly in specification of heart progenitors.</p><p>Apln receptor signaling is required for robust Nodal signaling, leading to an inability to efficiently up-regulate <italic>mespaa</italic> and <italic>mespab</italic> and specify cardiac progenitors.</p><p>In support of this conclusion over-expression of Nodal in the mutant/morphant embryos is sufficient to rescue the cardiac specification defects.</p><p>Essential revisions:</p><p>1) In revising the manuscript you should attempt to very clearly explain the cell autonomous versus non-autonomous roles for Aplnr in specification of the cardiac progenitors. This is somewhat confusing for the reader in light of your previous apparently contradictory findings published in Dev Cell and Biology Open. For example, wild type cells are unable to contribute to the heart in <italic>aplnra/b</italic> morphant host embryos, while <italic>aplnra/b</italic> morphant cells are able to contribute to heart in wild type embryos indicating non-autonomous role (Biol. Open 1: 275-285, 2012). However, placing <italic>agtrl1b (aplnrb</italic>) morphant cells in a wild-type environment did not appreciably rescue their ability to form myocardium, suggesting that Agtrl1b signaling is required autonomously in myocardial progenitors (Dev. Cell 12: 403-413, 2007). While you do discuss autonomous vs. non-autonomous roles in the Discussion, it would be helpful if your current conclusions could be summarized as a model (similar to Figure 6 of Biol. Open 2012).</p><p>2) It is also clear that there is an early endoderm defect in the double mutants. Knockdown of <italic>aplnra</italic> results in disrupted <italic>sox17</italic> expression levels and distribution, and that this is a similar phenotype to that observed in <italic>aplnrb</italic> knockdown. The <italic>aplnrb</italic> mutant has a normal endodermal organ development (Scott et al. Dev Cell), but it seems <italic>sox17</italic> expression at gastrulation stages has only been described in the double knockout using morpholinos, not in the single <italic>aplnrb</italic> mutant? Therefore, the disrupted <italic>sox17</italic> expression in the double knockout could simply be the consequence of knocking down the a variant. Have you analysed <italic>sox17</italic> expression in the <italic>aplnrb</italic> mutant/morphant to back up this claim?</p><p>3) Along the same lines it would be important to know if there are defects later in endodermal organ development in the double mutants. For example, does the gut develop normally, are the gut associated organs specified normally? While the cardiac phenotype (regulation of the <italic>mesp</italic> genes etc.) has been investigated fully, the effect of loss of <italic>aplnr</italic> function on the endoderm lineage, specification of which is regulated by dose-dependent Nodal signaling in both fish and mouse, was not investigated. More information should be included if possible to this point.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.13758.019</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p>Essential revisions:</p><p>1) In revising the manuscript you should attempt to very clearly explain the cell autonomous versus non-autonomous roles for Aplnr in specification of the cardiac progenitors. This is somewhat confusing for the reader in light of your previous apparently contradictory findings published in Dev Cell and Biology Open. For example, wild type cells are unable to contribute to the heart in aplnra/b morphant host embryos, while aplnra/b morphant cells are able to contribute to heart in wild type embryos indicating non-autonomous role (Biol. Open 1: 275-285, 2012). However, placing agtrl1b(aplnrb) morphant cells in a wild-type environment did not appreciably rescue their ability to form myocardium, suggesting that Agtrl1b signaling is required autonomously in myocardial progenitors (Dev. Cell 12: 403-413, 2007). While you do discuss autonomous vs. non-autonomous roles in the Discussion, it would be helpful if your current conclusions could be summarized as a model (similar to Figure 6 of Biol. Open 2012).</p><p>We agree with the reviewers and editors that we did not fully explain our model or these published discrepancies in the original manuscript. We have altered text in the Discussion (subsection “The Nature of the Aplnr Effect on Nodal Signaling”) to address this, and based on your excellent suggestion have added new model schematics (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2C-D</xref>) to illustrate our key points. As we now articulate in the Discussion, we believe these discrepancies in the literature potentially stem from the initial size of donor clones introduced in transplants, which may influence the neighbouring environment of a cell and therefore confuse interpretations of cellular autonomy of action of the Aplnr.</p><p>2) It is also clear that there is an early endoderm defect in the double mutants. Knockdown of aplnra results in disrupted sox17 expression levels and distribution, and that this is a similar phenotype to that observed in aplnrb knockdown. The aplnrb mutant has a normal endodermal organ development (Scott et al. Dev Cell), but it seems sox17 expression at gastrulation stages has only been described in the double knockout using morpholinos, not in the single aplnrb mutant? Therefore, the disrupted sox17 expression in the double knockout could simply be the consequence of knocking down the a variant. Have you analysed sox17 expression in the aplnrb mutant/morphant to back up this claim?</p><p>We thank the editors for providing the opportunity to include a more detailed examination of endoderm defects in <italic>aplnra, aplnrb</italic> and <italic>aplnra; aplnrb</italic> mutants (see point 3 below as well). We have added images and quantification of <italic>sox17</italic> expressing endoderm cells during gastrulation in single <italic>aplnrb</italic> mutants (<xref ref-type="fig" rid="fig1">Figure 1O</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E-F</xref>). We find that they exhibit a decrease in both the number of expressing cells and the spread of these cells when compared to WT that is not significantly different from <italic>aplnra</italic> single mutants. Double <italic>aplnra; aplnrb</italic> mutants however exhibit a further reduction in both <italic>sox17</italic> cell number and spread compared to the single mutants, as would be expected if <italic>aplnra</italic> and <italic>aplnrb</italic> have partially redundant functions.</p><p>3) Along the same lines it would be important to know if there are defects later in endodermal organ development in the double mutants. For example, does the gut develop normally, are the gut associated organs specified normally? While the cardiac phenotype (regulation of the mesp genes etc.) has been investigated fully, the effect of loss of aplnr function on the endoderm lineage, specification of which is regulated by dose-dependent Nodal signaling in both fish and mouse, was not investigated. More information should be included if possible to this point.</p><p>To address this point we have performed in situ hybridization for three different markers of the endoderm (<italic>foxa1, foxa2</italic> and <italic>foxa3</italic>) in double <italic>aplnra; aplnrb</italic> mutants. We find that at 48 hpf endoderm formation appears defective with significant abnormalities in the most anterior pharyngeal endoderm and the formation of the liver and pancreatic buds (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). It is likely that the variability seen in these phenotypes reflects the early deficit (but not absence) of endodermal progenitors formed in double mutants, although we cannot rule out a later function for Aplnra/b in endodermal organ development.</p></body></sub-article></article>